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Abstract
Patients with medically unexplained health complaints attributed to dental amalgam 
often wish to have their amalgam fillings replaced with other materials. The main 
purpose of this thesis was to explore how patients with health complaints attributed to 
dental amalgam experienced changes in health after removal of all amalgam fillings.
Forty patients with health complaints attributed to dental amalgam were included and 
assigned to a treatment group (n=20; amalgam removal) and a reference group (n=20; 
no treatment). An external reference group (n=441) from the general population was 
also used for comparisons with the treatment group. Follow-up in the treatment group 
included measurements of mercury in serum and urine and questionnaires with 
numeric rating scales for 6 intraoral, 5 extraoral, and 12 general health complaints. The 
same questionnaire was also used in the reference groups. After the final follow-up, 
twelve of participants in the treatment group were asked to participate in semi-
structured qualitative interviews exploring their experiences of changes in health after 
amalgam removal. Patterns and themes in the participants’ descriptions were identified 
through an explorative and thematic analysis of the transcribed interviews. 
In the treatment group, mercury concentration in serum and index scores for intraoral 
and general health complaints declined significantly three years after amalgam 
removal. In the reference group there was as a slight, but not significant, increase of 
index scores in the same period. Comparisons with the external reference group 
showed that even after amalgam removal, participants in the treatment group reported 
a significantly higher level of complaints for 6 of the 23 complaints. In the interviews, 
participants described feeling better after amalgam removal, but were reluctant to point 
to the removal as the only cause for their improved health. Despite not being sure of 
the importance of amalgam removal, all participants expressed that it had been 
important for them to get rid of the amalgam fillings. The mechanisms behind the 
reduced levels of health complaints after amalgam removal are probably compounded 
and not limited to reduced exposure to mercury. This was also acknowledged and 
underscored by the participants in the interview study.
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Dental amalgam, which has been used as a restorative material for almost 200 years 
(Brownawell et al., 2005; Rasines Alcaraz et al., 2014), has been crucial for the 
proliferation of affordable and durable dental treatment to the general population 
(Rathore, Singh, & Pant, 2012; Scientific Committee on Emerging and Newly-
Identified Health Risks (SCENIHR), 2008). Dental amalgam consists of 
approximately 50 percent metallic mercury (Hg) by weight, mixed with an alloy 
powder that usually consists of silver, tin and copper (Powers & Sakaguchi, 2006; 
SCENIHR, 2008). Mercury is a known toxicant (Bernhoft, 2012; Clarkson & Magos, 
2006), and the safety of dental amalgam has been questioned since it was first 
introduced into modern dentistry (Molin, 1992; Rathore et al., 2012; SCENIHR, 
2008). Due to its long history and widespread use, dental amalgam is presumably the 
most thoroughly investigated dental material to date, and reports of adverse reactions 
are considered rare (Kallus & Mjör, 1991). Nevertheless, there has been a recurring 
worry in the population that dental amalgam may cause ill-health (Molin, 1992; 
Mortensen, 1991; Rathore et al., 2012).  
In response to this concern, the government of Norway (Norwegian Board of Health, 
1999; Norwegian Directorate of Health, 2008) and other national governments, e.g. 
Sweden (Swedish National Board of Health and Welfare, 1987, 1994), Canada (Health 
Canada, 1996) and the United States of America (U.S. Food and Drug Administration 
(FDA), 2009; U.S. Public Health Service (USPHS), 1993, 1997) have funded reports 
and guidelines describing the use of, and potential risks associated with, dental 
amalgam. The World Health Organization (WHO, 2010) and the European Union 
(SCENIHR, 2008, 2015b) have also commissioned reports. So far, with the exception 
of contact reactions in the oral mucosa (Issa, Brunton, Glenny, & Duxbury, 2004), 
research and accumulated clinical experience have failed to demonstrate any strong 
evidence that patients’ health is compromised by their amalgam fillings. However, the 
need to consider potentially sensitive groups such as pregnant women and the 
developing fetuses has been addressed (Richardson et al., 2009), and there has been a 
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call for further research into the relationship between genetic polymorphism and 
sensitivity to mercury (Richardson et al., 2009; SCENIHR, 2015b).
Due to the increased quality of tooth colored fillings (mostly polymer-based 
composites), concerns over the environmental impact of mercury disposed of in the 
course of dental practice, and public concerns related to negative health effects from 
amalgam fillings, the use of dental amalgam has decreased (Mitchell, Koike, & Okabe, 
2007; Rasines Alcaraz et al., 2014). In Norway, products containing mercury have 
been banned since 2008 (Norwegian Ministry of the Environment and International 
Development, 2007). Dental amalgam, however, is still used in many countries 
throughout the world (Rasines Alcaraz et al., 2014), and due to its durability, patients 
will continue to keep their amalgam fillings for quite some time, even in countries 
where the use of dental amalgam has significantly declined or been banned 
(Anusavice, Shen, & Rawls, 2013b). Thus, the relationship between dental amalgam 
and health will be of continued importance.
1.1 Adverse reactions to dental amalgam 
Dental amalgam is a biomaterial used to restore lost tooth substance, usually due to 
caries. A biomaterial can be defined as “a substance that has been engineered to take a 
form which, alone or as a part of a complex system, is used to direct, by control of 
interactions with components of living systems, the course of any therapeutic or 
diagnostic procedure” (Biomaterials, 2016). By definition, a biomaterial is designed to 
interact with biological systems, and can as such potentially also cause adverse 
reactions. Adverse reactions to a dental material can be defined as “any unintended, 
unexpected, and harmful response of an individual to a dental treatment or a 
biomaterial” (Anusavice, Shen, & Rawls, 2013a, p. 111). Adverse reactions to dental 
treatment can occur as a consequence of mechanical or thermal affections due to the 
operative procedures, or as the result of either a toxic or allergic reaction to one or 
several of the components of the dental biomaterial (Anusavice et al., 2013a). 
Unfortunately, it is often difficult to identify the mechanisms behind the adverse 
reactions (Anusavice et al., 2013a; Kallus & Mjör, 1991). In a study from 1991 (Kallus 
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& Mjör), the incidence of adverse reactions to dental materials, both subjectively 
reported by patients and clinically identified by dentists, was at a level of 1 per 700 
treatments. Lichenoid reactions to amalgam restorations were the most frequent long-
term side effects (Kallus & Mjör, 1991).  
Dental amalgam and other materials used for dental restorations are classified as 
medical devices in the European Union as well as in the United States, being regulated 
as medium risk devices (Class II) (European Economic Community (EEC), 1993; 
FDA, 2009). 
1.1.1 Allergic reactions  
It is generally accepted that dental amalgam fillings can lead to local contact reactions 
(Issa et al., 2004; McParland & Warnakulasuriya, 2012). Oral lichenoid contact lesions 
(OLCLs) are found in direct topographic relationship with the dental material thought 
to have caused the reaction (Al-Hashimi et al., 2007). In the majority of cases, the 
suspected material is dental amalgam. If the material is removed, most OLCLs will 
improve or heal within months (Al-Hashimi et al., 2007; Issa et al., 2004). For dental 
amalgam, the oral lichenoid contact reactions are associated with delayed type 
hypersensitivity (Holmstrup, 1991; McParland & Warnakulasuriya, 2012; Mårell, 
Tillberg, Widman, Bergdahl, & Berglund, 2014). Other factors may also play a role, 
such as local toxic reactions and plaque build-ups on the fillings (Holmstrup, 1991). 
Rare cases of assumed immediate generalized hypersensitivity reactions to dental 
amalgam have also been reported (see for instance Kal, Evcin, Dundar, Tezel, & Unal, 
2008; McGivern, Pemberton, Theaker, Buchanan, & Thornhill, 2000).
The Norwegian guidelines for examination and treatment of patients with suspected 
adverse reactions to dental biomaterials (Norwegian Directorate of Health, 2008) 
recommend replacement of dental restorations in direct contact with lesions in the oral 
mucosa. Replacement of fillings is also recommended if other hypersensitivity 
reactions to the dental materials have been shown (Norwegian Directorate of Health, 
2008).
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1.1.2 Toxic reactions  
The main concern regarding the safety of dental amalgam has been related to the 
material’s high content of mercury. Mercury is a metal that can be found in its 
elemental form as metallic mercury or mercury vapor. It can also be found in inorganic 
compounds, such as mercurous and mercuric salts, and in organic compounds such as 
methylmercury and ethyl mercury (Berlin, Zalups, & Fowler, 2015; Bernhoft, 2012). 
Mercury is a known toxicant (Bernhoft, 2012; Clarkson & Magos, 2006), and all forms 
of mercury can be toxic to humans (Berlin et al., 2015). The toxicological effects 
depend on the form of mercury one has been exposed to (Berlin et al., 2015; Bernhoft, 
2012; Brownawell et al., 2005; Clarkson & Magos, 2006) as well as dose, duration and 
route of exposure (Berlin et al., 2015; Bernhoft, 2012). In the general population, the 
main sources for mercury exposure are dental amalgam (elemental mercury/mercury 
vapor) and consumption of fish (methylmercury) (SCENIHR, 2015b; WHO, 1991).
People can also be exposed to mercury through their work, for instance in the 
chloralkali industry (production of chlorine and caustic soda) or as dental workers 
(Brownawell et al., 2005; WHO, 1991).  
It is a well-established fact that amalgam fillings release low levels of mercury vapor 
into the oral cavity (Brownawell et al., 2005). With the exception of the increased 
mercury exposure that can occur when amalgam fillings are placed, polished or 
removed (Haikel, Gasser, Salek, & Voegel, 1990), the exposure to mercury from 
amalgam fillings can be described as a chronic low level exposure (Brownawell et al., 
2005). Numerous studies have found statistically significant correlations between the 
number of amalgam fillings and concentration of mercury in blood (Björkman et al., 
2007), urine (Olstad, Holland, Wandel, & Pettersen, 1987), saliva (Lygre et al., 1999) 
and the brain (Björkman et al., 2007; Eggleston & Nylander, 1987). Thus, the question 
is not whether amalgam fillings release mercury, but rather the extent to which the 
released mercury can cause ill-health at these predominantly low levels.
Most of our knowledge about the toxicity of elemental mercury has been derived from 
studies of people occupationally exposed to mercury vapor (Richardson et al., 2011; 
SCENIHR, 2008). Patients with amalgam fillings have, generally speaking, 
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substantially lower levels of mercury in respiratory air, blood, and urine than people 
who are exposed to mercury vapor through their work (Clarkson & Magos, 2006; 
SCENIHR, 2015b). In a study from 1998 (Sandborgh-Englund et al.), the daily dose of 
mercury was estimated at 5-9 micrograms/day in patients with an ordinary number of 
amalgam fillings. A summary of reports published in the late 1990s on mercury 
released from amalgam fillings estimated that daily mercury exposure from amalgam 
fillings ranged from 1 to 10 micrograms/day (Ekstrand, Björkman, Edlund, & 
Sandborgh-Englund, 1998). In comparison, the Scientific Committee on Emerging and 
Newly-Identified Health Risks (SCENIHR, 2015b, p. 27) referred to an occupational 
limit of 70 micrograms/day for exposure to elemental mercury vapor. However, there 
is considerable individual variation when it comes to release and uptake of mercury 
from amalgam fillings, and some patients can present with mercury levels in plasma 
and urine comparable to levels found in people with high exposure to mercury through 
their work (Barregård, Sällsten, & Järvholm, 1995; Clarkson & Magos, 2006; 
SCENIHR, 2015b; Sällsten, Thorén, Barregård, Schütz, & Skarping, 1996).  
Exposure to mercury vapor can cause neurological signs (Berlin et al., 2015), and high 
levels of exposure can lead to tremors, behavioral changes, personality changes, 
increased excitability, loss of memory, and insomnia (Berlin et al., 2015). In addition, 
symptoms such as gingivitis, stomatitis, excessive salivation, and, in some cases, 
kidney damage have also been seen in people with high occupational exposure to 
mercury vapor (Clarkson & Magos, 2006). These symptoms, however, are associated 
with exposure to mercury at much higher levels than levels normally associated with 
exposure to mercury from amalgam fillings. The possibility of adverse effects at lower 
exposure levels has been debated (Clarkson & Magos, 2006). At lower levels, the 
effects of mercury, if present, are likely to manifest as nonspecific symptoms which 
make it difficult to detect and diagnose possible chronic low level mercury poisoning 
(Clarkson & Magos, 2006; Homme et al., 2014).  
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1.1.3 Uncertainty related to the safety of dental amalgam 
At the request of the European Union, the Scientific Committee on Emerging and 
Newly Identified Risks has prepared and adopted two scientific opinions on the safety 
of dental amalgam and alternative dental restoration materials for patients and users 
(SCENIHR, 2008, 2015b). In the opinions, scientific studies addressing adverse effects 
related to amalgam fillings are described, and the scientific evidence for the reported 
associations is evaluated. In the most recent opinion (SCENIHR, 2015b) it is stated 
that:
It is recognised that mercury, which is the major metallic element used in 
dental amalgam, does constitute a toxicological risk, with reasonably well-
defined characteristics for the major forms of exposure. The reduction in use of 
mercury in human activity would be beneficial, both for the general decrease in 
human exposure and from environmental considerations. (p. 42) 
Even though dental amalgam is comprised of several metals, the potential adverse 
effects of mercury have been given the most attention. In the most recent opinion 
(SCENIHR, 2015b), the risks associated with other elements than mercury was 
summarized as follows: “There is no scientific evidence that any of those elements 
currently used in dental amalgam restorations constitute a risk of adverse health effects 
in individuals apart from allergic reactions to the individual elements”(p. 26). In the 
opinion (SCENIHR, 2015b), the scientific committee acknowledged that local adverse 
effects in the oral cavity can occur when amalgam fillings are used. These reactions, 
however, were described as rare and easy to manage. In regard to possible systemic 
effects of mercury exposure from amalgam fillings, the committee categorized the 
scientific evidence as weak and concluded that “no increased risks on adverse systemic 
effects have been documented in the general population” (SCENIHR, 2015b, p. 43). 
However, the committee (SCENIHR, 2015b) also described studies (see for instance 
Basu, Goodrich, & Head, 2014) indicating that relatively common genetic variations 
can be associated with increased susceptibility to mercury exposure, and the 
committee stressed the need for further research into the possible significance this can 
have for exposure to mercury from amalgam fillings. Despite acknowledging that 
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reduced use of mercury would be beneficial and that further research is needed to 
better understand the effects of genetic polymorphism on individual susceptibility to 
mercury, the committee concluded that “dental amalgam is an effective restorative 
material for the general population, with low risk of adverse health effect” (p. 71). 
This is in line with conclusions from previous official reports on the safety of dental 
amalgam (see for instance Norwegian Board of Health, 1999; FDA, 2009; USPHS, 
1997). For the majority of patients with amalgam fillings, the absorbed daily dose of 
mercury from the fillings seems to be quite low (Mackert & Berglund, 1997) and the 
estimated levels of exposure are well below levels permitted for occupational exposure 
(Clarkson & Magos, 2006; SCENIHR), 2015b). However, as described both in the 
scientific opinion (SCENIHR, 2015b) and elsewhere (see for instance Homme et al., 
2014; Richardson et al., 2009; Richardson et al., 2011), there are uncertainties 
connected with the potentially adverse effects for sensitive individuals, and it has been 
argued that the current regulatory safety standards lack safety margins (Homme et al., 
2014; Richardson et al., 2011). In addition, some of the assumptions made by the 
scientific committee (SCENIHR, 2008) regarding the toxicology of mercury have been 
criticized (Mutter, 2011).
1.2 Patients with health complaints attributed to dental 
amalgam 
Patients with health complaints attributed to dental amalgam constitute a 
heterogeneous patient group (Langworth, Björkman, Elinder, Järup, & Savlin, 2002; 
Lindh, Hudecek, Danersund, Eriksson, & Lindvall, 2002). Common to all patients is 
the phenomenon that they suffer from unexplained, or partially explained health 
complaints that they or their dentist or physician believe are caused or aggravated by 
their amalgam fillings. A wide range of complaints related to multiple organ systems 
has been associated with amalgam fillings (Furhoff et al., 1998; Langworth et al., 
2002; Malt et al., 1997). Tiredness, headaches, pain in muscles and joints, and 
problems with memory and concentration are among the most frequently reported 
complaints (Langworth et al., 2002; Lygre, Gjerdet, & Björkman, 2005; Vamnes, 
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Lygre, Grönningsæter, & Gjerdet, 2004). With the exception of local contact reactions 
(Al-Hashimi et al., 2007; Issa et al., 2004) and rare generalized hypersensitivity 
reactions (Kal et al., 2008; McGivern et al., 2000), the reported complaints mainly fall 
into the category of subjectively reported complaints. This means that the complaints, 
such as pain from muscles and joints, tiredness, headaches and so on, are based on 
patients’ descriptions and cannot be identified through visual inspection, laboratory 
tests, radiographs et cetera. It is important to underline that this does not imply that the 
complaints are not real or not debilitating. It does, however, make the diagnostic 
process more difficult as there can be both competing and multiple explanations for 
the complaints.
Due to the wide range of reported complaints, as well as the mostly subjective nature 
of the complaints, there are no stringent criteria for identifying and describing patients 
with health complaints attributed to dental amalgam, or “amalgam patients” as they are 
sometimes also referred to. In the research literature, slightly different criteria for 
inclusion and exclusion have been applied. In a study from Norway (Malt et al., 1997), 
physicians and dentists who believed in the existence of an amalgam syndrome were 
asked to provide criteria for identifying patients with such a condition. The included 
practitioners deemed the following central in describing the patient group: “Multiple 
physical and psychological complaints developed over time starting with a few 
symptoms and gradually escalating to multiple symptomatology. Fluctuation in the 
clinical symptomatology may occur.” (Malt et al., 1997, p. 33). The practitioners also 
provided an extensive list of complaints likely to be reported by amalgam patients 
(Malt et al., 1997). When investigating health complaints attributed to dental amalgam, 
some studies have relied on, and expanded on, questionnaires regarding common 
health complaints, such as the Giessener Symptom Complaints Checklist (Malt et al., 
1997; Nerdrum et al., 2004), whereas other studies have used self-constructed 
questionnaires with health complaints that the researchers, based on the existing 
research literature and their own clinical experience, believe are core symptoms 
reported by patients with health complaints attributed to dental amalgam (Lygre et al., 
2005; Melchart et al., 2008; Zwicker, Dutton, & Emery, 2014).
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1.2.1 Psychological distress  
The majority of studies investigating the relationship between subjectively reported 
health complaints and dental amalgam have been cross-sectional, and among their 
main findings is a high prevalence of psychological distress reported by patients with 
health complaints attributed to dental amalgam (see for instance Bailer et al., 2001; 
Bågedahl-Strindlund et al., 1997; Langworth et al., 2002; Malt et al., 1997). In several 
of the studies (Bailer et al., 2001; Bågedahl-Strindlund et al., 1997; Gottwald, Kupfer, 
Traenckner, Ganss, & Gieler, 2002; Malt et al., 1997) the high comorbidities between 
amalgam-related complaints and somatization, anxiety and depression were stressed, 
and based on the lack of findings linking the health complaints to mercury 
concentration in blood and urine, the researchers concluded that patients’ complaints 
were more likely to have psychological than toxicological causes. The cross-sectional 
design of these studies does however make it difficult to say how the psychological 
distress and the reported physical health complaints are related.
In addition, inventories for anxiety and depression usually contain items addressing 
somatic aspects such as poor sleep, lack of appetite, et cetera, and can as such be 
influenced by the patients’ experience of poor health. This could potentially have 
inflated the numbers characterized as suffering from anxiety and depression. However, 
it should also be noted that the somatic manifestations of both depression and anxiety 
can be interpreted by the patients themselves as signs of illness/disease not related to 
the psychological condition itself. This brings us closer to the understanding of 
somatization applied in some of these articles (see for instance Bågedahl-Strindlund et 
al., 1997; Gottwald et al., 2002; Langworth et al., 2002; Malt et al., 1997), i.e. as “a 
tendency to experience and communicate psychological distress in the form of 
physical symptoms, and to seek medical help for them“ (Lipowski, 1987, p. 161). 
However, it has been amply described that patients living with health complaints 
which cannot be fully explained may experience psychological distress as a result of 
not being believed, being unable to establish an explanation for the complaints, and 
having to “fight” the medical profession and the social services to get sick leave, 
disability pension et cetera (Aamland, Werner, & Malterud, 2013; Kornelsen, Atkins, 
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Brownell, & Woollard, 2015; Nettleton, 2006). In view of all this, it is perhaps better 
to use the following definition of somatization: “the existence of physical bodily 
symptoms in the absence of a known medical condition” (Merriam-Webster Medical 
Dictionary, 2016). This does not mean that it can be dismissed that psychological 
distress can play a part in causing, upholding and exacerbating the experienced health 
complaints; it does mean, however, that one needs to proceed with caution when 
speculating about possible causal relationships between comorbid conditions. 
1.2.2 Negative life events 
In a study from 2002 (Langworth et al.), findings from semi-structured clinical 
interviews showed that a large number of patients had experienced negative life events 
earlier in life or shortly preceding the start of their amalgam-related symptoms, and 
many of the patients also reported having a stressful social situation and a poor social 
network. This led the authors to suggest that the tendency to somaticize that they also 
had identified in their sample could, in some cases, “be seen as a way of coping” 
(Langworth et al., 2002, p. 711). In a study from 2011 (Sundström, Bergdahl, Nyberg, 
Bergdahl, & Nilsson), cross-sectional analysis revealed that patients with health 
complaints related to dental amalgam reported having experienced significantly more 
negative life events than matched controls. In both groups the most frequently reported 
negative life event was somatic illness or surgical operation which was reported by 
41% of the amalgam patients and 27% of the controls. The amalgam group reported 
more often than the controls that the life event was unexpected and that it was difficult 
to adjust to the event. The amalgam patients also reported having had lower control 
over the event than the control group. 
1.2.3 Worry 
We define amalgam patients as people who believe their medically unexplained, or 
partially explained, health complaints are caused or aggravated by their amalgam 
fillings. Consequently, worry related to potentially negative health effects from 
amalgam fillings can be considered a defining characteristic of this patient group. This 
has also been described in other studies: “A common finding was profound anxiety 
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about a connection between their symptoms and dental amalgam” (Langworth et al., 
2002, p. 711). For anxiety patients, a cognitive processing priority for information 
related to their specific fears has been thoroughly demonstrated, and it has been argued 
that a similar mechanism could be important for the development and maintenance of 
medically unexplained complaints (Brosschot, 2002). People with a very strong 
concern or worry about somatic disease are likely to develop a cognitive bias for 
information related to somatic disease, and as such, bodily sensations and other 
information related to their worries could be experienced and interpreted as indicating 
ill-health. Increased monitoring of bodily sensations in combination with an increased 
risk of misattributing and/or over-reporting ambiguous stimuli, could potentially lead 
to increased reporting of health complaints (Brosschot, 2002). In a similar manner it 
has been suggested that the popular media’s preoccupation with possible links between 
illness and toxic and environmental causes can influence the way people experience 
and interpret nonspecific and common symptoms (Petrie et al., 2001). In a study from 
New Zealand (Petrie et al., 2001), a significant, albeit moderate, correlation was found 
between modern health worries and total number of self-reported health complaints. In 
a prospective study of the influence of modern health worries on symptom reporting, it 
was found that higher levels of modern health worries were associated with a higher 
number of complaints being attributed to pesticide after a planned pesticide spraying 
of participants’ residential area (Petrie et al., 2005). The authors (Petrie et al., 2005) 
suggested that modern health worries can influence people’s symptom expectations in 
such a way that, when activated by an actual situation, their bodily sensations and 
health complaints are monitored and interpreted within a confirmatory framework 
associated with the worry/worries in question.
1.2.4 Effects of amalgam replacement on subjective health 
complaints
There is a scarcity of prospective studies investigating the effects of amalgam 
replacement on subjective health complaints. In Table 1, examples of prospective 
studies with comparison groups are listed. Only one (Melchart et al., 2008) of the 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































categorized as prospective cohort studies (Grimes & Schulz, 2002) if, in this context, 
we conceptualize the cohort as patients who were examined at a clinical unit because 
of health complaints attributed to dental amalgam. In the studies, patients were asked 
to participate in follow-ups sometime after the initial examinations. Comparisons 
could then be made between patients who had their amalgam fillings removed in the 
time since the initial examination and patients who chose not to remove their amalgam 
fillings. This is a simplified description of the design of the studies. For details and 
exemptions, see Table 1. 
In all of the studies, some kind of improvement of health was reported by the patients 
who had all their amalgam fillings removed (Table 1). Different explanations, 
including patients’ expectations (Melchart et al., 2008; Nerdrum et al., 2004; Tillberg 
et al., 2005), psychosocial treatment effects (Nerdrum et al., 2004), elimination of 
worry (Nerdrum et al., 2004), spontaneous recovery (Tillberg et al., 2005), and the 
natural course of the complaints (Melchart et al., 2008), were suggested for the 
reported improvements in health. However, not all of the reported reductions were 
statistically significant, and the complaints that were statistically reduced varied from 
study to study (not described in Table 1, see for instance Lygre et al., 2005; Zwicker et 
al., 2014). In the randomized controlled trial (Melchart et al., 2008), clinically relevant 
reductions of health complaints were found for all interventions, including the one 
without amalgam removal. In the studies with reference groups from the general 
population, health complaints after amalgam replacement were still higher, or more 
frequent, than health complaints found in the general population (Lygre et al., 2005; 
Nerdrum et al., 2004; Tillberg, Mårell, Berglund, & Eriksson, 2008).  
In the studies that included measures of mercury, significant reductions of mercury 
were found after amalgam removal (Melchart et al., 2008; Stenman & Grans, 1997; 
Zwicker et al., 2014). In one of the studies (Zwicker et al., 2014), a significant 
reduction of mercury was also found in the non-removal group. The authors suggested 
this could have been due to all participants being offered detoxification supplements.  
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1.2.5 Disease, illness and sickness 
Patients with health complaints attributed to dental amalgam have, as a group, 
encountered medical and dental services that have not been able to fully explain and 
cure their health complaints. It is our understanding that some of the difficulties 
patients and health professionals experience when faced with unexplained health 
complaints are rooted in the biomedical understanding of disease.  
Within the biomedical model, it is assumed that disease can “be fully accounted for by 
deviations from the norm of measurable biological (somatic) variables” (p. 130, Engel, 
1977). To separate the objective, measurable aspects of disease from the subjective 
experiences of the patient and the way these experiences influence the patients’ 
interactions with society, a distinction is often made between disease, illness and 
sickness (Engel, 1977; Hofmann, 2002). Disease is used to describe measurable 
physiological malfunctions that could result in actual or potential diminished physical 
capacity/life expectancy (Hofmann, 2002). Disease is often, but not always, 
accompanied by illness experiences, i.e. the patient’s subjective experience of having 
an undesirable state of health (Hofmann, 2002). Sickness refers to a social identity 
(sick role) that comes into play when the illness experience interferes with the 
patient’s ability to participate in his or her everyday life (Hofmann, 2002).  
In the paper “The Need for a New Medical Model: A Challenge for Biomedicine”, 
Engel (1977) gave examples from both psychiatry and somatic medicine that could not 
be adequately addressed with a biomedical approach to disease, and he suggested that 
the biomedical model should be broadened to also encompass psychological, social 
and cultural determinants of health. Even though it can be argued that there has been a 
shift towards a biopsychosocial understanding of health, the application of this 
understanding in research and clinical settings is probably still hindered by factors 
such as the convenience of tradition and lack of time and resources to fully consider 
and address the psychosocial determinants of the patients’ health (Alonso, 2004). 
Given that the biomedical model was also embraced as a folk model in Western 
societies (Engel, 1977), the imprint of this model still influences the way patients and 
their family, friends and colleagues understand health and disease.  
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For patients with unexplained health complaints, the main hurdle posed by the 
biomedical model is being diagnosed with a disease in the first place. When a non-
contested disease label is lacking, both patients and society may find it difficult to 
make sense of the patients’ illness complaints, and the patients may also find it 
difficult to find acceptance for their illness in their everyday encounters and when 
asking for sick leave or applying for disability pension. 
In our articles and in this summary, we use terms such as subjectively reported health 
complaints and unexplained health complaints. These terms are informed by the 
terminologies of subjective health complaints (SHC) (Eriksen & Ihlebæk, 2002; 
Ihlebæk, Eriksen, & Ursin, 2002; Ursin, 1997) and medically unexplained symptoms 
(MUS) (Brown, 2007). The term SHC was suggested by Ursin (1997) to provide a 
neutral, descriptive term for health complaints/diagnostic groups mainly depending on 
subjective statements from the patients themselves. MUS is another term used to 
describe such complaints and can be defined as “a heterogeneous group of conditions 
characterized by persistent physical symptoms that cannot be explained by medical 
illness or injury” (Brown, 2007, p. 769). 
1.2.6 The importance of patients’ experiences 
The work presented in this thesis has been guided by the belief that to fully engage 
with and hopefully also in some ways alleviate patients’ suffering, health personnel 
and researchers need to listen to the patients themselves. Patients’ experience their 
health complaints in their everyday lives, and the meaning and the perceived 
consequences of the health complaints are contingent on patients’ previous 
experiences, reactions from significant others, as well as the perceived present and 
longtime impact on their ability to carry out their duties, care for themselves and 
others, and of course, on their perceived chances of survival. Patients carry all this 
with them, both consciously and subconsciously, when they try to manage and make 
sense of their health complaints.  
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1.3 Thesis focus 
As already described, the scientific community has been unable to state unequivocally 
whether dental amalgam is safe or not. The current understanding seems to be that “the 
question of ‘amalgam sensitivity’ should concentrate more on individual vulnerability, 
either in the form of biological (e.g. genetic) or psychosocial (e.g. personality, 
experiences, health beliefs and concerns) predisposition” (SCENIHR, 2015a, p. 9-10). 
This is an important step towards acknowledging that although there is an abundance 
of support for dental amalgam being a safe treatment alternative at group level, there 
are some uncertainties related to the safety of dental amalgam for potentially sensitive 
subgroups. The question is not limited to “is dental amalgam safe or not”, but has been 
broadened to include issues regarding sensitive subgroups, possible interactions et 
cetera. Despite this broadening of perspective pertaining to the relationship between 
dental amalgam and health, patients with subjective health complaints attributed to 
dental amalgam will probably find that the association between their health complaints 
and their amalgam fillings is still best characterized as ranging from “not likely” to 
“uncertain”. As such, their illness experiences are still associated with unclear disease 
status and a lack of indicated treatment strategies. Regardless of these uncertainties, 
patients with health complaints attributed to dental amalgam often wish to have their 
amalgam fillings removed. 
 
Against this backdrop, we wanted to investigate what effects, if any, can be reasonably 
anticipated when patients decide to have their amalgam fillings removed. In 
continuation of this, we also wanted to gain knowledge about how patients with health 
complaints attributed to dental amalgam experience, describe and assign meaning to 
changes in health complaints before and after amalgam removal.  
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2. Aims  
The overall hypothesis for the quantitative studies was that removal of all amalgam 
fillings in a group of patients with health complaints attributed to dental amalgam 
would be associated with long-lasting reductions of the complaints.  
 
The general aim of the qualitative studies was to explore how patients who attributed 
health complaints to dental amalgam experienced changes in health complaints before 
and after amalgam removal. 
 
The specific aims were: 
- To investigate whether amalgam removal was associated with long-lasting 
reductions of composite scores for intraoral, extraoral and general health 
complaints (Paper I). 
- To investigate whether amalgam removal was associated with reductions of 
mercury concentration in serum and urine (Paper I). 
- To investigate and describe changes of each of the individual health complaints 
included in the composite scores (Paper II). 
- To explore how patients came to the associate their health complaints with 
dental amalgam (Paper III). 
- To explore how patients gave meaning to changes in health complaints before, 
during and after amalgam removal (Paper IV). 
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3. Material and methods 
The work presented in this thesis originates from the Bergen Amalgam Trial which 
consists of a clinical trial and an interview study. Paper I and Paper II draw upon data 
from the clinical trial (Figures 1 and 2). Paper III and IV present findings from the 
interview study (Figure 1). Readers are referred to the individual papers for details.  
 
Figure 1: Study groups, methods for data collection and focus for analyses for Papers I–IV.
a
Full name
of the Unit: the Dental Biomaterials Adverse Reaction Unit.
b
Changes in mercury concentration in
serum and urine in the amalgam removal group were investigated.
c
Reference group sampled in
relation to a previous study (Lygre et al., 2005).
d




3.1 Clinical trial 
3.1.1 Design 
The clinical trial was designed as an interventional before-and-after study with a no-
treatment comparison group. In this text and in the papers, the terms reference group 
and internal reference group are frequently used to refer to the comparison group. The 
study population consisted of patients with unexplained health complaints attributed to 
dental amalgam. Included participants were assigned to a treatment group (amalgam 
removal) or a reference group (no treatment). For some analyses, results from the 
treatment group were compared with results from an external reference group from the 
general population. 
3.1.2 Participants and procedure  
Participants: Participants were recruited from patients referred to the Dental 
Biomaterials Adverse Reaction Unit during the years 1993 to 1999. In this period, 368 
patients were examined at the unit. In 2000–2001 all patients with known contact 
information (n=358) received a questionnaire in the mail. The questionnaire was 
returned by 207 of the patients, yielding a response rate of 58 percent. The 
questionnaire contained questions about current health situation, medical and dental 
treatment since the examination at the unit, and demographic variables. Based on 
available data from the initial examination and information given in the questionnaires, 
50 patients were found qualified under the following inclusion criteria:  
(i) Initially referred to the unit for examination of health complaints attributed 
to amalgam fillings 
(ii) Amalgam fillings still present 
(iii) Not diagnosed with contact allergy to substances in resin-based dental 
materials 
(iv) Health complaints from at least three different organ systems 
(v) Available data on mercury in blood and urine from initial examination 
(vi) Age 25-55 at initial examination 
(vii) Accepted to be contacted in a follow-up study 
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The 50 included patients were randomized to a treatment group (n=20 + 10 reserves) 
and a reference group (n=20). Based on clinical documentation, telephone interviews 
and dental and medical examinations (pre-treatment examination), six of the twenty 
participants assigned to the treatment group were excluded according to the following 
criteria: 
(i) Severe medical disorders (e.g. multiple sclerosis, ALS, severe rheumatoid 
arthritis) 
(ii) Severe food allergies 
(iii) Psychological difficulties or psychiatric disorders that could influence the 
dental treatment 
(iv) Need for complicated dental therapy (severe periodontitis, high caries 
activity, and/or need for complicated dental rehabilitation – e.g. bridges) 
(v) Inclusion criteria no longer fulfilled  
 
The main reason for using these exclusion criteria was to ensure that the amalgam 
removal process could be carried out with as little risk and inconvenience as possible 
for the participants. The same exclusion criteria were applied in the group of reserves, 
leaving six participants eligible to replace the excluded participants. This left us with a 
treatment group of 20 participants (14 female, 6 male) and a reference group of 20 
participants (16 female, 4 male). See Figure 2 for participant flow through the study. 
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Figure 2: Flow diagram showing participant flow in the study. a Current addresses were missing for
ten patients. b Did not fulfill inclusion criteria. c Excluded according to exclusion criteria. d Had
removed all amalgam fillings. This figure was also used in Paper I (Sjursen et al., 2011).
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Intervention: Participants in the treatment group had all amalgam fillings removed and 
replaced with other dental restorative materials (e.g. composites, ceramic restorations 
and metalloceramic crowns) by their own dentists. The cost was covered by project 
funds, and the dentists were asked to follow clinical guidelines from the adverse 
reaction unit aimed at limiting the exposure from mercury during removal sessions 
(Norwegian Dental Biomaterials Adverse Reaction Unit, 2002). The amalgam removal 
was performed by 18 dentists. One dentist treated three of the participants; 17 dentists 
treated one participant each. The main aim for the clinical trial was to compare 
replacement of amalgam fillings with the standard dental treatment (i.e. no removal of 
amalgam fillings) for patients with subjective health complaints attributed to dental 
amalgam. Consequently, no intervention was assigned to the reference group. 
Clinical examinations: Data from the initial examination at the unit during the period 
1993 to 1999, including data on mercury in blood and urine, was available for all 
participants. In addition, participants in the treatment group underwent a medical and 
dental examination at a pre-treatment examination in 2002. Dental examinations were 
also carried out at all follow-ups. Serum samples were collected at the pre-treatment 
examination and at all follow-ups; urine samples were collected at the pre-treatment 
examination and at the one year follow-up.  
Questionnaires: Questionnaire 1 (Q1), which was used for inclusion in the study, was 
also used as a baseline measurement of self-reported health complaints for 
comparisons between the treatment group and the reference group. The scheduling of 
the subsequent measurements of health complaints differed between the treatment 
group and the reference group (see Figure 3 for a timeline of the study). In the 
treatment group, questionnaire data were collected at the pre-treatment examination in 
2002 and at follow-ups three months and one, three and five years after completed 
removal of dental amalgam. In the reference group, questionnaires were administered 
by regular mail. Participants were sent Questionnaire 2 (Q2) in 2004 and 
Questionnaire 3 (Q3) in 2007.  
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External reference group: For some analyses, we compared the treatment group from 
this trial and an external reference group used in a previous study (Lygre et al., 2005). 
The external reference group was sampled based on similarity to patients referred to 
the Adverse Reaction Unit regarding age, gender and education. Questionnaires were 
sent to 800 individuals during the spring of 2004 and returned by 441 of them, 
resulting in a response rate of 55 percent. 
 
Figure 3: Timeline for the trial for the treatment group and the reference group. Q1, Q2 and Q3
indicate Questionnaire 1, Questionnaire 2 and Questionnaire 3. Timeframes for the data collection
are given at the top for the treatment group and at the bottom for the reference group.
3.1.3 Measures  
Self reported health complaints: The presence and perceived intensity of self-reported 
health complaints were measured by numeric rating scales (NRS) for 23 health 
complaints often reported by patients with health complaints attributed to dental 
amalgam (Appendix). The scales were constructed at the adverse reaction unit and 
have been used in a previous study of a similar patient population (Lygre et al., 2005). 
Of the 23 items, 12 were related to general health complaints and 11 were related to 
orofacial complaints (complaints relating to the mouth and face). The orofacial health 
complaints were further categorized as intraoral (6 items) or extraoral health 
complaints (5 items). Participants were asked to indicate the intensity of their 
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complaints on horizontal scales marked with numbers ranging from 0 to 10. The scales 
were also verbally anchored with “No complaints” at the left side and “Worst possible 
complaints” on the right side. Index scores for intraoral, extraoral and general health 
complaints were constructed by adding the scores for all items within each category. 
The internal consistency, as measured by Cronbach’s alpha using the entire 
randomized sample (n=50), was found to be 0.66, 0.72 and 0.80 respectively for the 
intraoral, extraoral and general health complaints indices.  
Mercury concentration in serum and urine: Concentration of mercury in blood serum 
was analyzed by inductively coupled plasma-sector field mass spectrometry (ICP-
SFMS) (Rodushkin, Engström, Stenberg, & Baxter, 2004). Concentration of mercury 
in urine was analyzed by cold vapor atom absorption spectrometry (Vamnes, Eide, 
Isrenn, Höl, & Gjerdet, 2000). 
3.1.4 Statistical analyses 
Statistical analyses were conducted using the SPSS software, version 15 (SPSS Inc.). 
All significance tests were two-tailed. P-values < 0.05 were considered significant.  
Power calculation:After application of the inclusion criteria, only 50 participants 
were eligible for participation in the clinical trial. After application of the exclusion 
criteria in the treatment group and the group of reserves, only 40 participants were left 
(20 participants in the treatment group and 20 participants in the reference group). 
Power calculations were made in order to determine if this sample would be sufficient 
to test the null hypothesis that changes in index scores for general health complaints 
were the same in the two groups. Assuming a mean difference in index scores of 10.0 
between the two groups (that is, a mean difference of 10.0 in the treatment group from 
before amalgam removal to after amalgam removal versus a mean difference of 0.0 in 
the reference group between the score from Questionnaire 1 to the score from a later 
administered questionnaire), and a within-group standard deviation of 10, a sample 
size of 20 participants in each group will give the study a power of 87 percent to yield 
a statistically significant result. 
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Paper I  Independent samples t-tests were used for baseline comparisons between 
groups. The P-values from these analyses were not included in the manuscript. Within-
group changes in health complaints over time were examined using mean values with 
95-percent confidence intervals and repeated measures analysis of variance. These 
analyses were carried out as both intention-to-treat (ITT) and per-protocol (PP) 
analyses in both groups. Last observation carried forward was used to replace missing 
values for ITT analyses. Paired sample t-tests were used to investigate changes in 
mean mercury concentration in serum and urine from pre-treatment examination to 
follow-ups. Mean values (i.e. mean changes in the treatment group minus mean 
changes in the reference group) with 95-percent confidence intervals and independent 
samples t-tests were used for unadjusted comparisons of both per-protocol and 
intention-to-treat differences of changes in the treatment group and the reference 
group. Analysis of covariance was used to adjust for age, gender and complaint 
intensity at Q1 when comparing the changes in health complaints in the two groups.  
 
Paper II  Paired sample t-tests were used to investigate changes in health complaints 
from the pre-treatment examination to the three-year follow-up in the treatment group. 
Effect sizes were calculated as standardized response means (SRM) with values of  
0.20,  0.50 and  0.80 representing small, moderate and large responsiveness. Mann-
Whitney U-test and independent samples t-test were used to test differences in health 
complaints scores between the treatment group and the external reference group. 
Correlations between variables were investigated with Spearman’s correlation.  
 
3.2 Interview study  
3.2.1 Design 
To supplement the findings from the quantitative analyses of the self-report 
questionnaires, we wanted to carry out qualitative research interviews with some of the 
participants from the treatment group after they had completed all follow-ups after the 
amalgam removal. The motivation behind this was twofold:  
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(i) We wanted to explore the participants’ experiences on their own terms to 
gain insight into how they have lived with, interpreted and given meaning to 
their experiences of changes in health complaints before, during and after 
amalgam removal. 
(ii) We also wanted to use the interviews as means to generate new hypotheses 
for further research and to open up for inclusion of additional relevant 
questions to questionnaires used in this patient group.  
 
Prompted by the emphasis on exploration in both aims, we chose to carry out an 
explorative and reflexive thematic analysis of semi-structured interviews. Collection 
and analysis of data were strongly influenced by the step-by-step guides provided by 
Braun and Clarke (2006) and Binder, Holgersen, and Moltu (2012). Braun and Clarke 
(2006) described thematic analysis as “a method for identifying, analysing and 
reporting patterns (themes) within data” (p. 79), and they emphasized that thematic 
analysis can be applied by researchers informed by a range of theoretical approaches. 
In contrast to more pure phenomenological (i.e. descriptive/essentialist) or 
hermeneutic (i.e. interpretative) approaches, the explorative and reflexive approach to 
thematic analysis described by Binder et al. (2012) encourages the researchers to 
pursue both the descriptive (explorative) and the interpretative (reflexive) aspects of 
their material. This, however, is contingent on transparent descriptions of the steps 
undertaken by the researchers in order to arrive at the presented set of findings. In 
particular, researchers have to be aware of, and willing to scrutinize the tension 
between staying true to the participants’ idiosyncratic or personal descriptions of their 
experiences, while at the same time being able to use the patterns of shared and 
divergent experiences to give meaningful interpretative descriptions of the 
participants’ experiences. In order to address this tension as unreservedly as possible, 
the researchers are also expected to engage in self-reflection on how their social, 
cultural, professional and personal backgrounds and their relationship to the 
participants influence the research process and the way the findings can be interpreted 
(Binder et al., 2012).  
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3.2.2 Participants  
We used a purposive sampling procedure. Participants were recruited from the 
treatment group in the amalgam trial, thus ensuring that they all had been through a 
complete removal of dental amalgam. Participants completed their amalgam removal 
at different times; consequently their follow-ups also took place at different times. The 
first six participants who finished the five-year follow-up were asked to participate in a 
qualitative research interview. The next six participants we asked were selected to 
ensure that both sexes and a diverse age range were represented. When we had 
completed the twelve interviews, we were able to identify both divergent and 
convergent experiences in the interview material and we had the impression that no 
new themes were brought to light during the last interviews. Seven women and five 
men participated in the interviews. Participants’ age range was 45-65 years (mean age 
54.4 years) at the time of the interviews. 
3.2.3 Procedure 
With the aim of facilitating an open dialogue with the participants suitable for the 
exploration of how they had experienced changes in health complaints before, during 
and after amalgam removal, we chose to carry out semi-structured, exploratory in-
depth interviews with one participant at the time . All interviews took place at the 
neuropsychological outpatient clinic at the University of Bergen. Separate cameras 
were used to make video recordings of the participants and of the interviewer (me). 
Co-supervisor Knut Dalen was present at the outpatient clinic during all interviews. 
Neither of us had been present at the follow-ups at the Adverse Reaction Unit. The 
interview guide was initially developed by all coauthors of Paper III and Paper IV. 
After each interview, Knut Dalen and I discussed our first impressions of the 
interview. If needed, we also adjusted the interview guide. Mean duration of the 
interviews was 60 minutes (range 32 min. – 2 h 9 min.) 
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3.2.4 Analyses  
We performed an explorative and reflexive thematic analysis (Binder et al., 2012; 
Braun & Clarke, 2006). Through comparing participants’ individual accounts we 
wanted to identify patterns of similarities and differences in their experiences of 
changes in health complaints before, during and after amalgam removal. The steps in 
the analyses were the same for Paper III and Paper IV, but the focus was guided by the 
research question for each paper. The steps in the analyses can be summarized as 
follows:  
(i) Therese T. Sjursen (TTS/me) transcribed all video recordings verbatim.  
(ii) All authors read through the transcripts individually so they could get a 
basic sense of patterns in the participants’ experiences.
(iii) Each author discussed their first impressions of the written material with a 
special emphasis on patterns they thought constituted meaningful themes 
with TTS.
(iv) TTS organized the text material into nodes in accordance with the tentative 
themes from step (iii). This systematic organization was carried out with the 
technical assistance of the NVivo9 software (QSR International Pty Ltd., 
2010).
(v) Based on TTS’ written descriptions of the themes, the themes were further 
refined and condensed in cooperation with the coauthors. This was done as a 
combination of verbal discussions and written feedback to the drafts of the 
findings sections for Papers III and IV.
(vi) To strengthen the transparency of our analyses, quotes and examples were 
included in the papers to illustrate patients’ experiences.  
 
3.3 Ethical approval 
The project protocol for the Bergen Amalgam Trial was approved by the Regional 
Committee for Medical and Health Research Ethics in Western Norway (REK III 
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nr.24.01), and by the Norwegian Social Science Data Services. The trial was registered 
at ClinicalTrials.gov (NCT00346944). The protocol for the interview study was also 
approved by the Regional Committee for Medical and Health Research Ethics in 
Western Norway and by the Norwegian Social Science Data Services. Written consent 
was obtained from all participants at the start of the amalgam trial, and, for participants 
in the interview study, before agreeing on a date for the interview. Findings are 
presented without details that can identify individuals. 
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4. Summary of results 
4.1 Paper I 
“Changes in health complaints after removal of amalgam fillings” 
The aim of this study was to investigate whether removal of all amalgam fillings in a 
group of patients with health complaints attributed to dental amalgam was associated 
with long-term changes in health complaints and mercury concentration in serum and 
urine. Changes in health complaints in the treatment group from Questionnaire 1 to the 
three-year follow-up were compared with changes in health complaints from 
Questionnaire 1 to Questionnaire 3 in a comparable reference group.  
 
Between group comparisons: Per-protocol comparisons of changes in health 
complaints showed that changes in mean index scores for intraoral (7.9; 95% CI: 1.1 to 
14.7; P = 0.024) and general (18.4; 95% CI: 6.8 to 30.0; P = 0.003) health complaints 
were significantly different in the two groups, whereas changes in extraoral index 
scores (3.2; 95% CI: -3.7 to 10.2; P = 0.036) were not significantly different in the two 
groups.  
 
Within group changes  In the treatment group we found statistically significant 
reductions in mean index scores for intraoral (3.7; 95% CI: 0.5 to 6.9) and general 
health complaints (9.7; 95% CI: 4.4 to 15.0) from Questionnaire 1 to the three-year 
follow-up. The reduction in extraoral health complaints in the same period (1.5; 95% 
CI: -2.8 to 5.8) was not statistically significant. In the reference group, all index scores 
increased from Questionnaire 1 to Questionnaire 3. The changes in the reference group 
were however not statistically significant. 
 
Mercury concentration: In the treatment group, mercury concentration in serum and 
urine was significantly reduced after amalgam removal. 
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4.2 Paper II 
 “Characterization of health complaints before and after removal of amalgam 
fillings – 3-year follow-up” 
The aim of this study was to describe changes in the 23 health complaints that were 
used to construct the index scores presented in Paper I. The levels of the complaints 
were also compared with levels of complaints in an external reference group.  
Within group changes  There was a general decrease of mean intensity of health 
complaints from the pre-treatment examination to the three-year follow-up with the 
exception of small increases in intraoral burning sensation and visual disturbances, and 
no changes in intraoral stiffness/paresthesia and dry mouth. The variation between 
participants was high. Statistically significant reductions were found for taste 
disturbances, pain from muscles and joints, gastrointestinal symptoms, symptoms from 
ear, nose and throat, and fatigue. No significant correlations were found between the 
change scores for these five items and reduction of mercury in serum. Reductions of 
one or more general health complaints were seen for all patients (n=19) in the 
treatment group; reductions of one or more orofacial complaints were seen for 17 
patients. 
Within group correlations at pre treatment: At pre-treatment, several significant 
positive correlations were found between complaints. Gastrointestinal problems, for 
instance, were positively correlated with facial skin problems, visual disturbances, 
fatigue, dizziness, memory problems and difficulty concentrating.  
Between group comparisons: At the pre-treatment examination, mean intensities of all 
complaints were higher in the treatment group than in the external reference group. At 
the three-year follow-up, the mean intensities of facial pain and tenderness, pain from 
temporomandibular joints, pain in muscles and joints, gastrointestinal symptoms, 
memory problems and difficulty concentrating were still significantly higher in the 
treatment group than in the external reference group.   
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4.3 Paper III 
 “How unexplained health complaints were attributed to dental amalgam” 
In this article, we explored how the participants remembered and described the 
experiences that led them to attribute their health complaints to dental amalgam. We 
found the following five themes to be of central importance for forming such an 
attribution: 
i. Feeling puzzled: All participants described suffering from health complaints 
that they could not fully understand. 
ii. Picking up anecdotal evidence: All participants described having heard about 
possible adverse reactions to dental amalgam before, but such anecdotal 
evidence did not seem to lead to an attribution of health complaints to dental 
amalgam unless encountered at a time when the patient was particularly open 
for such a connection. 
iii. Temporal relationship between dental treatment and episodes of ill-health: 
Some of the participants first started suspecting dental amalgam after having 
experienced episodes of ill-health and/or onset of long-lasting complaints in 
relation to dental treatment involving dental amalgam. 
iv. A trusted person suggested dental amalgam as an explanation for my 
complaints: Almost half of the participants said that either their physician or 
their dentists were the first to suggest a link between their health complaints 
and dental amalgam.  
v. Feeling a resonance with descriptions of amalgam poisoning: When the 
association between dental amalgam and health complaints had been brought to 
the participants’ attention through one or several of the ways described in the 
previous themes, descriptions of amalgam poisoning in the media or obtained 
from patient organizations seemed to be of importance for examining the 
personal relevance of the attribution. For most of the participants, this resulted 
in a feeling of recognition and confirmation of the attribution.
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4.4 Paper IV 
 “Patients’ experiences of changes in health complaints before, during and after 
amalgam removal” 
In this article we explored how the participants experienced and gave meaning to 
changes in health complaints before, during and after amalgam removal. Through our 
analysis of the participants’ experiences we found the following themes to be of 
importance: 
i. Something is not working: betrayed by the body: All participants described the 
experience of something not working inside their bodies. Some seemed 
confused, and even betrayed, by their overly sensitive bodies. 
ii. You are out there on your own: Most of the participants had actively searched 
for explanations for their health complaints. Several expressed disappointment 
in how difficult it had been to get help from the medical profession, and some 
of the participants had also turned to chiropractors, physiotherapists and 
practitioners of alternative medicine for help. 
iii.  Not being sure of the importance of amalgam removal: Most of the participants 
reported feeling better after amalgam removal, but due to difficulties in 
untangling effects of other changes in their lives from the effects of amalgam 
removal, participants found it difficult to claim with certainty that the changes 
were caused by the removal. 
iv.  The relief experienced after amalgam removal: Despite not being able to point 
to dental amalgam as the sole explanation for feeling better, the majority of 
participants reported that they were in a much better place in their lives than 
before the amalgam removal and that they believed that the removal was 
partially responsible for this. In addition, all participants expressed relief that 
they no longer had to worry about their amalgam fillings. 
v. To accept, to give up, or to continue the search: For many of the participants, 
the amalgam removal seemed to have led to reduced urgency in their search for 
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answers, and some participants seemed to have moved towards accepting their 
health complaints.  
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5. Discussion 
5.1 Methodological considerations 
In this thesis, both quantitative and qualitative approaches have been used to 
investigate changes in health complaints before and after amalgam removal. 
Regardless of whether the approach is quantitative or qualitative, scientific inquiry is 
characterized by the application of systematic methods for collection, organization and 
interpretation of data material (Kazdin, 2003; Malterud, 2001). 
In quantitative research, the collected data is expressed as numbers, and investigation 
and analyses are usually carried out according to pre-determined and strictly defined 
research questions. The quantitative method is the method of choice if we want to 
estimate the prevalence or incidence of a condition in a given population, or if we want 
to establish causality, for instance when investigating the effects of an exposure or a 
treatment. However, despite its obvious importance for medical progress, quantitative 
research with its focus on “phenomena that can be controlled, measured and counted” 
(Malterud, 2001, p. 397), is not necessarily the best approach to answer questions 
about how patients’ experience their conditions, their treatment regimens and their 
interactions with health personnel, friends, family et cetera. 
For research aims related to patients’ experiences, qualitative research that aims “to 
investigate the meaning of social phenomena as experienced by the people 
themselves” (Malterud, 2001, p. 398) is a better choice. In qualitative research, the 
collected data is expressed as words and data collection is often carried out through 
interviews. However, blog posts, patients’ diaries and even patients’ artwork can also 
constitute sources for analysis. Analysis, however, is usually carried out on textual 
material, for instance interview transcripts. The research questions are usually open-
ended and continuously evolve both during data collection and analysis of data. In 
qualitative research, the aim of being able to identify themes and patterns in the data 
material should always be balanced with appreciation and preservation of participants’ 
idiosyncratic experiences.  
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In the individual papers included in this thesis, we chose not to apply a mixed-methods 
design. This choice was grounded in the acknowledgement of the different levels of 
analysis and different knowledge claims associated with quantitative and qualitative 
research methods. Nevertheless, as findings from both the quantitative and the 
qualitative studies are discussed in this thesis summary, the thesis in itself can be 
described as having a design close to an explanatory sequential mixed-methods design 
(Creswell, 2014, p. 224). Our design is a two-phase design where we first carried out a 
quantitative study followed by a qualitative study. However, even though the 
qualitative study was designed with the intent of using the findings from the interviews 
to supplement and nuance the findings from the clinical trial, we did not systematically 
use the quantitative results to plan the second qualitative phase. 
The thrust of the research, however, has been carried out within either a quantitative or 
a qualitative framework, and therefore, the following discussion of methodological 
considerations will be described separately for the clinical trial and the interview 
study. 
5.1.1 Clinical trial 
In the clinical trial we wanted to investigate the effects of amalgam removal on 
changes in subjective health complaints. The inferences we can draw from our 
findings are contingent on both the design and the execution of our study. See Figure 4 
for a short description of the questions associated with the internal, external and 
construct validity of an experimental study. 
Internal validity: In treatment research, internal validity refers to the degree to which 
it can be surmised that the observed outcome is caused by the treatment and not by 
extraneous factors (Kazdin, 2003; Slack & Draugalis, 2001). Ideally, when 
investigating the effects of a treatment, the only difference between the groups should 
be the treatment(s) under investigation. In experimental studies, researchers can exert 
more control over extraneous variables than in observational studies. Randomized 
controlled trials (RCTs) are experimental studies in which participants are randomized 
to the different treatment conditions. This is done with the aim of reducing selection 
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bias and to disperse potential confounding participant characteristics across all groups 
in the trial. In evidence based medicine, RCTs are frequently placed high in 
hierarchies of evidence (Grimes & Schulz, 2002; Hannan, 2008), and to further reduce 
bias such as observer bias and responder bias, blinded or double blinded 
administration of treatment is preferential. Due to necessary modifications of 
randomization and follow-up, however, the design of our study does not qualify as an 
RCT. Instead it can be categorized as a quasi-experimental study or as a non-
randomized clinical trial, or, when more detail is needed, as an interventional before-
and-after study with a no-treatment comparison group. Several threats to the internal 
validity of experimental studies have been described (Kazdin, 2003; Slack & 
Draugalis, 2001). Some of these will be discussed below. 
 
Figure 4: Questions addressed by internal, external and construct validity. Descriptions adapted from
Table 2.1, page 23, in Kazdin (2003).
History and maturation refer to possible influences of events because of the passage of 
time (Kazdin, 2003; Slack & Draugalis, 2001). History refers to events other than the 
intervention that could influence the outcome of the experiment. To be considered a 
threat to internal validity, the historical events (which could be events in the news, at 
work, at home etc.) should affect all or the majority of the subjects and the 
hypothesized effects on the results have to be plausible. In our study, the most likely 
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influences of history are changes in caretaking responsibilities in relation to children 
growing up, parents growing older and parents dying. Maturation refers to 
psychological and physiological processes within the participants that may change 
with the passage of time, such as growing wiser, growing older, reaching menopause 
et cetera. However, due to the demographic similarities between the treatment group 
and the reference group, similar effects of history and maturation are likely to occur in 
both groups.  
Regression to the mean refers to the phenomenon that people with very high or very 
low scores are likely to have less extreme scores the next time they are measured 
(Kazdin, 2003; Slack & Draugalis, 2001). However, given the fact that participants in 
the reference group had higher levels of health complaints at baseline and that they did 
not report reductions of health complaints, regression to the mean does not seem to be 
a plausible explanation for the differences in changes between the two groups. 
Selection bias refers to the presence of systematic differences between groups that 
were present before administration of treatment or that were somehow introduced 
during the course of the study (Kazdin, 2003; Slack & Draugalis, 2001). If these 
differences influence the outcome of the study (i.e. act as confounds) the inferences we 
draw based on our findings can be biased either towards accentuation or attenuation of 
the effect of the treatment. Selection bias can be eliminated or substantially reduced by 
randomizing participants to the different treatment conditions. In our study, 
participants were randomized to a treatment group, a group of reserves and a reference 
group. After randomization, exclusion criteria were applied in the treatment group in 
order to ensure that the amalgam removal would not be too burdensome for the 
participants. This could have introduced a selection bias connected to known (more 
severe conditions in the reference group than the treatment group) and unknown 
variables. This could pose a threat to the internal validity if, for instance, participants 
in the reference group suffered from progressive conditions to a greater extent than 
participants in the treatment group. Reduced health complaints in the treatment group 
could thus be hypothesized as associated with the natural variation of less severe 
complaints, whereas lack of changes, or increased health complaints, in the reference 
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group could be associated with participants’ health condition either remaining 
unchanged or deteriorating due to other conditions. Baseline comparisons showed that 
even though the two groups were similar in regard to demographic variables, the 
reference group did in fact report higher levels of health complaints than the treatment 
group. The differences between the groups, however, were not statistically significant, 
and the reported changes of intraoral and general health complaints three years after 
amalgam removal remained statistically significant when adjusted for gender, age and 
complaint intensity at baseline (Paper I). Post-hoc application of exclusion criteria in 
the reference group resulted in exclusion of only two of the initial twenty participants 
(Paper I). Comparisons of per-protocol changes in the treatment group and the 
reference group with the two participants excluded yielded similar result as 
comparisons of per-protocol changes between the treatment group and the full 
reference group. As a side note, application of exclusion criteria was motivated by 
ethical and practical considerations and should not be interpreted as a dismissal of an 
association between dental amalgam and the excluded conditions. 
Attrition and diffusion of treatment can also threaten the internal validity (Kazdin, 
2003; Slack & Draugalis, 2001). Attrition, or experimental mortality, refers to 
participants lost to follow-up, and diffusion of treatment refers to situations where 
treatment is inadvertently administered to the control group. Attrition can introduce 
selection bias to the study if the loss to follow-up is different in the treatment group 
and the reference group, either through more participants dropping out from one of the 
conditions or through participants dropping out for different reasons from the two 
groups. Given that the participants in the reference group were not offered any 
treatment, it was expected that the loss to follow-up would be greater in the reference 
group than in the treatment group. In addition, it was expected that some of the 
participants in the reference group would choose to initiate amalgam removal on their 
own accord during the follow-up period. For ethical and practical reasons, participants 
in the reference group were only followed-up by questionnaires sent by regular mail. If 
asked to participate in clinical examinations and follow-ups, participants would be 
reminded to a greater extent of a possible association between their health complaints 
and their amalgam fillings. Given that the participants in the reference group would 
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not be offered treatment, it seemed unethical to ask them to go through with such an 
extensive follow-up regime. It was also speculated that extensive follow-up would 
increase participants’ wish to have their amalgam fillings removed, which might result 
in withdrawal from the study due to participants’ disappointment in not being offered 
such treatment, and diffusion of treatment through participants initiating amalgam 
removal on their own accord. Consequently, the follow-up in the two groups differed 
substantially. Despite the limited follow-up in the reference group, the loss to follow-
up in this group was greater than in the treatment group (Figure 2). Participants from 
the reference group who confirmed that they had removed all amalgam fillings were 
excluded from analyses (Figure 2).  
To summarize, there are apparent threats to the internal validity of the study. However, 
some of the threats, such as maturation and history, are probably evened out across 
groups, and some of the other threats have been controlled for in statistical analyses 
that render them less plausible as rival explanations for the effect of the intervention. 
However, even if we consider the different changes in the two groups as a result of the 
intervention (amalgam removal), we still have to consider threats to external validity 
and construct validity. 
External validity: In treatment research, external validity refers to the degree to which 
the effect of the treatment can be generalized to other people and other settings than 
the ones investigated in the experiment (Kazdin, 2003; Slack & Draugalis, 2001). The 
generalizability of the results is therefore highly dependent on the representativeness 
of the sample studied as well as the transferability of the treatment conditions from the 
experimental setting to the relevant natural settings. In experimental studies, the 
internal validity is often high. However, due to often strictly defined inclusion and 
exclusion criteria, the external validity of experimental studies has been criticized. In 
our study sample characteristics, stimulus characteristics and settings and research
participation effects are the most important threats to the external validity (Kazdin, 
2003; McCambridge, Witton, & Elbourne, 2014). 
Sample characteristics such as age, gender and socioeconomic status have to be 
considered when discussing the generalizability of the results. The participants 
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included in our sample were recruited from patients referred to the Adverse Reaction 
Unit for health complaints attributed to dental amalgam. Therefore, it is not certain 
that patients with subjective health complaints who do not attribute their health 
complaints to their amalgam fillings would achieve similar reductions of health 
complaints after amalgam removal. The generalizability of the results to all patients 
with subjective health complaints attributed to dental amalgam can also be questioned. 
At the initial examination at the Unit, no recommendation was made to the participants 
that they have their amalgam fillings removed, and in the period between the 
examination and inclusion into the study, they had not had all amalgam fillings 
removed on their own initiative. The reasons for this could be related to participants 
trusting the advice given at the Unit and/or not having the financial means necessary to 
have amalgam removed. This means that the results are not necessarily generalizable 
to participants with a stronger conviction and/or an economic status enabling them to 
carry out amalgam removal. However, follow-up studies of participants having had 
their amalgam fillings removed on their own initiative have also found reduced health 
complaints after amalgam removal (Lygre et al., 2005; Nerdrum et al., 2004; Tillberg 
et al., 2005). 
Stimulus characteristics and settings refer to the possibility that the treatment effects 
obtained in the experimental condition could be contingent on, or influenced by, 
features of the study that are not necessarily transferable to other treatment settings 
(Kazdin, 2003). Research participation effects refers to the potential effects on 
participants’ behavior from the knowledge that one is being studied, and conversely, 
these are not likely to occur in a setting where patients are not participating in a study 
(McCambridge, Kypri, & Elbourne, 2014; McCambridge, Witton, et al., 2014). Both 
of these threats to external validity can also affect construct validity and will therefore 
be discussed in more detail in the next section. 
Construct validity: The construct validity of an experimental study has to do with how 
the causal relation found in the study is interpreted (Kazdin, 2003). In our study, even 
though there are obvious threats to the internal validity, it does seem that the 
intervention in the treatment group caused changes in the treatment group that were 
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not found in the reference group. Whether these changes are caused by the amalgam 
removal or other components associated with the amalgam removal should be 
considered, however. In the next sections, non-specific factors related to the treatment 
context will be discussed. These factors can influence both the generalizability 
(external validity) and the construct validity of the study. 
Placebo: People who are skeptical of a link between dental amalgam and health 
complaints are quick to interpret reported changes in health complaints after amalgam 
removal as a placebo effect. Strictly speaking, placebos are “drugs, devices or other 
treatments that are physically and pharmacologically inert” (Wager & Atlas, 2015, 
p.403). Consequently, placebo interventions will not have any direct treatment effects 
(Wager & Atlas, 2015). Therefore, the placebo effect, which is a true psychobiological 
response (Price, Finniss, & Benedetti, 2008), must be interpreted as elicited by the 
context in which the treatment was administered (Wager & Atlas, 2015). Even though 
originally used to describe the effect of inert treatment, the placebo effect, along with 
its counterpart the nocebo effect, is now increasingly used to also denote the non-
specific treatment effects (i.e. effects not caused by the intervention itself) of any 
medical treatment (Hauser, Hansen, & Enck, 2012). Wager and Atlas (2015, p. 403) 
described placebo effects as “brain-body responses to context information that 
promote health and well-being”, and they advocated that a large part of the therapeutic 
response to medicaments, surgery, psychotherapy et cetera is likely to have been 
caused by the treatment context rather than the specific interventions. Consequently, 
some of the reported changes in health complaints after amalgam removal can have 
been caused by non-specific treatment responses. For instance, it can be speculated 
that the experienced changes have been accentuated by both internal and external 
context information (Wager & Atlas, 2015), such as the patients’ expectations that 
amalgam removal would lead to reduced health complaints as well as a presumably 
positive treatment atmosphere while undergoing the necessary dental treatment at their 
own dentists. However, this does not preclude that some of the experienced changes 
are due to specific treatment effects of the amalgam removal. 
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Nocebo: In addition, albeit undoubtedly difficult to untangle from the placebo effect, 
the nocebo effect, or rather discontinuation of the nocebo effect, may also have 
influenced the experienced reductions in health complaints. In the same way as 
placebo effects originally referred to beneficial effects of inert or sham interventions, 
nocebo effects originally referred to adverse effects or worsening of symptoms in 
response to an inert/sham treatment (Hauser et al., 2012). However, nocebo response 
can also be used to refer to adverse effects or exacerbated symptoms caused by 
internal and external context information, such as negative expectations or negative 
communication, both verbal and non-verbal, in the treatment setting (Hauser et al., 
2012). It cannot be excluded that for patients with health complaints attributed to 
dental amalgam, some of the experienced health complaints could be thought of as 
nocebo effects elicited by the fear that the amalgam fillings may cause ill-health. This 
information, however, is more likely to have come from stories in the media or from 
acquaintances, for instance, than from the dentists who originally treated the patients. 
Moreover, once this worry had been elicited, the black amalgam fillings might have 
served as a constant visible reminder of the potentially detrimental health effects 
related to the fillings. When the amalgam fillings were removed, it is reasonable to 
assume that potential nocebo responses as well as the worry associated with the 
fillings were eliminated.  
Research participation effects: The mere act of participating in a study can lead to 
changed behavior and biased reporting. This can make it difficult to study the targeted 
phenomenon without influencing the outcome through observing and interacting with 
the participants. This has often been referred to previously as the Hawthorne effect 
(McCambridge, Kypri, et al., 2014; McCambridge, Witton, et al., 2014). Recently the 
term “research participation effects” has been suggested to highlight the effects that 
knowing one is being studied can have on participants’ behavior (McCambridge, 
Kypri, et al., 2014; McCambridge, Witton, et al., 2014). In prospective studies, 
repeated data collection brings attention to aspects of the participants’ lives that they, 
perhaps, would not have given as much thought to if they were not participating in the 
study. This can result in participants looking at and interpreting the measured variables 
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in new ways, as well as in changes in behavior, which obviously can also influence the 
results. In addition, there is also a risk that, to come across as good subjects, 
participants may consciously or unknowingly modify or weigh their responses to 
match what they perceive as the researchers’ goals (McCambridge, Kypri, et al., 
2014). Even though it is unlikely that the participants remembered in detail how they 
rated their health complaints at the pre-treatment examination and at the different 
follow-ups, we have to consider that the wish to convey gratitude and to show that 
amalgam removal can be considered an efficient treatment alternative can have 
influenced the way in which the participants interpreted and reported their health 
complaints at each measurement point.  
Stimulus characteristics and settings: In addition to the treatment effects either 
directly or indirectly caused by the amalgam removal itself, and possible research 
participation effects, it is also possible that the participants in this study can have had 
treatment effects related to the follow-up given both by their dentists and by the 
personnel at the Adverse Reaction Unit. It is well known that patient-centered 
communication can have health promoting effects (Stewart, 1995; Van Dulmen & 
Bensing, 2002), and many of the interviewed participants highlighted that they had felt 
well taken care of both at the Adverse Reaction Unit and by their own dentists (Paper 
IV). Health personnel with a genuine interest in the patients and sufficient time to 
listen to their experiences conducted the pre-treatment examination and all follow-ups 
at the Adverse Reaction Unit. It is not unlikely that these encounters can have had 
positive effects on patients’ health through their experiences of being seen and heard, 
but also through being given the opportunity to reflect upon possible connections 
between their health complaints and other areas of their lives. This aspect was perhaps 
most strongly voiced by one participant who emphasized that the questions asked by 
the project’s physician at the pre-treatment examination had initiated a change towards 
making more room for herself in her life (Paper IV).  
In summary, we find it reasonable to believe that all these factors can have influenced 
the results. Based on findings from the interviews, we believe that patient-centered 
communication, both in the dentist’s office and at the Adverse Reaction Unit, was of 
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particular importance. In addition, participants’ descriptions of relief related to having 
had their amalgam fillings removed indicate that discontinuation of nocebo effect and 
elimination of worry were also important for the reported reductions of health 
complaints. This has important implications for the generalizability of our findings and 
for the construct validity of our study as it can be speculated that our results are 
contingent on not only the amalgam removal but also on the patient-centered 
communication at the dentists and at the Adverse Reaction Unit. In addition, the 
potential effects of the amalgam removal in itself are not necessarily derived only from 
reduced mercury exposure given that discontinued nocebo effect/elimination of worry 
also could have influenced the results. 
5.1.2 Interview study 
Reflexivity: The preconceptions, personal values and previous experiences we as 
researchers, clinicians and individuals bring into the research process influence the 
questions we ask, the interactions we partake in, the inferences we draw and the 
findings we choose to present. In quantitative research, the aim is to limit the 
influences of anything other than the independent variables of interest, and some of the 
available methods/procedures for this were discussed under methodological 
considerations for the clinical trial. In qualitative research, the researchers’ role in co-
constructing the findings is acknowledged, and it is understood that research carried 
out by other researchers in a different context would result in different findings 
(Finlay, 2002). Nevertheless, we still have to actively investigate how the subjective 
aspects, such as our preconceptions, and intersubjective aspects, such as how we 
engage in creating meaning together with the research participants, influence our 
research and our findings. Reflexivity, which can be defined as “thoughtful, conscious 
self-awareness” (Finlay, 2002, p. 532) can be used systematically to carry out a 
continual, reflexive analysis of the way the subjective and intersubjective elements 
interact with and influence the research process.  
In our study, we as researchers, and I as the interviewer, actively shaped the research 
process through the questions we decided to include in the interview guide, through 
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the themes I chose to explore, or not to explore, during the interviews, and through the 
subsequent analysis and interpretation of the transcribed interviews. Throughout the 
research process, we sought to actively analyze and reflect upon how our 
preconceptions and our experiences of the unfolding research process influenced the 
way we engaged with the participants and the data material. Analyzes and reflections 
were carried out both individually and collectively.  
The risk of interpreting participants’ descriptions through a clinical lens was among 
the topics we discussed collectively. Each co-author for Papers III and IV has a 
clinical background. Therefore, it was important that we were able to take a step back 
from a purely anamnestic interpretation of participants’ descriptions so that we could 
better tune in on participants’ experiences of living with these health complaints. This 
aim was something that we had to remind ourselves of at different times during the 
research process. Of course, as health personnel, we are also obligated to use our 
clinical knowledge to identify the need for treatment and act upon it; procedures for 
this were in place for the interviews. Throughout the research process, we also had 
ongoing discussions about how patients with subjective health complaints are often 
described as strongly dismissive of psychological and social explanations for their 
health complaints. Despite the fact that we consider such categorizations both 
inaccurate and unhelpful, there is nevertheless a risk that a societal preconception such 
as this could influence our interactions with the participants and the way we interpret 
our findings. However, since one of our findings is that all the participants pointed to 
several explanations for their health complaints, including social and psychological 
explanations, this notion has been thoroughly disconfirmed for the participants in our 
sample. On the other hand, the desire to avoid just such a “preconception trap” may 
have prompted us to highlight participants’ attempts to explain their complaints within 
a multifactorial framework. Given my own understanding of health as determined by 
many factors, there is a risk that I, through subtle cues, might have encouraged the 
interview participants to describe their experiences within such a framework. Knut 
Dalen, who listened in on the interviews, did however have the impression that all 
explanations were met with equal encouragement. Nevertheless, this could have been 
experienced differently by the participants themselves. 
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Scope and limitations: The sample characteristics discussed in the section for external 
validity for the clinical trial, such as strength of the amalgam attribution and lack of 
financial means necessary for amalgam removal, are also relevant for the scope of the 
findings from the interviews. The experiences described by our participants are likely 
to be different from the experiences of patients with a stronger conviction that their 
health complaints are caused by their amalgam fillings, and also from the experiences 
of patients who can finance amalgam removal on their own. We also have to consider 
the effects participation in the clinical trial may have had on participants’ experiences 
of changes in health. The systematic collection of data through questionnaires and 
dental examinations, as well as the obvious amalgam focus of the follow-ups, may 
have influenced participants’ experiences of changes in health and how they perceive 
the association between dental amalgam and health.  
Even though the interviews took place in a different setting than the follow-ups, it was 
evident that participants thought of the interviews as a continuation of the clinical trial. 
Limitations related to the interview context, such as prompting explanations suitable 
for medical encounters, the context-related accentuation on the importance of 
amalgam removal and the wish to present a coherent picture of experienced changes in 
health complaints, are discussed in more detail in the Reflexivity, scope and 
limitations-sections of Papers III and IV. Some of these limitations could perhaps have 
been reduced if we had chosen to carry out focus group interviews instead of 
individual interviews. For instance, it is reasonable to assume that the wish to present a 
coherent picture could have become less salient in a focus group interview where 
participants would have been exposed to a variety of experiences, some similar to their 
own and some diverging from their own. Through participants listening to descriptions 
of each other’s’ experiences, it is also likely that they could have been triggered to 
remember and think of a greater range of experiences than in the individual interviews. 
However, there are also advantages related to carrying individual interviews. It can, 
for instance, be easier to address more personal and private aspects of participants’ 
experiences in individual interviews.  
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In summary, we have to acknowledge that we have only gained insight into parts of 
the participants’ experiences, and because of the interview context and our research 
questions, the importance of the amalgam attribution and the amalgam removal can 
have been inflated. 
5.2 Ethical considerations 
5.2.1 Clinical trial
For participants in both the treatment group and the reference group in the amalgam 
trial, there was a risk that participation in the study would lead to an increased focus 
on amalgam fillings and health complaints, which in turn could potentially result in 
increased health complaints and discomfort. Participants in the treatment group were 
informed about possible side effects from new fillings and possible complications 
connected with the dental procedures. To minimize the risk of complications, the 
dentists followed written guidelines on how to remove the dental amalgam 
(Norwegian Dental Biomaterials Adverse Reaction Unit, 2002). The participants in the 
reference group were not asked to go through a clinical examination at the beginning 
of the study, and they did not receive any treatment. This was done to reduce the 
possibility of participants in the reference group choosing to remove their dental 
amalgam on their own because of the re-examination. Due to lack of proven 
interventions for amalgam-related health complaints without objective findings, the 
lack of treatment in the reference group is deemed acceptable by ethical standards 
(World Medical Assosciation, 2013, Paragraph 33). 
5.2.2 Interview study 
Participants were asked to participate in the interview study at the final follow-up five 
years after amalgam removal. Extra care was taken to communicate that participants 
were under no obligation to participate in the interview study; nevertheless, given the 
context, there is a risk that participants might have felt obligated to comply with the 
request. However, our impression was that they were eager to participate, and some 
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said they were happy to get a chance to elaborate on the answers they had given in the 
questionnaires. The focus for the interviews was on attribution of health complaints to 
dental amalgam and experienced changes in health complaints before, during and after 
amalgam removal. We did make it clear, however, that we were interested in other 
aspects of their lives that might have influenced their health and quality of life. As 
with participation in the amalgam removal trial, there was a risk that asking 
participants to focus on dental amalgam and health complaints might result in 
perceived increased health complaints and discomfort. There was also a risk that 
participation in the interview could trigger other emotional issues. All interviews were 
carried out by Therese T. Sjursen (me), who is a psychologist, and under the 
supervision of Knut Dalen, who is a specialist in clinical neuropsychology. The 
interviews were scheduled at times when Dalen could be present if something should 
arise. Dalen watched video recordings of each interview, and Dalen and Sjursen 
discussed the content of the interviews during the same workday when they were 
carried out. All participants were instructed that they should contact the Adverse 




Overall, the results from the quantitative studies support the hypothesis that removal of 
all amalgam fillings in a group of patients with health complaints attributed to dental 
amalgam is associated with long-lasting reductions of the complaints. These results 
were supported, but also further nuanced, by the findings from the qualitative studies. 
In addition, the qualitative findings have given us increased insight into the active role 
of patients when it comes to experiencing, acting upon and giving meaning to health 
complaints without corresponding objective medical findings.  
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5.3.1 Reduced health complaints after amalgam removal 
The participants in the treatment group reported that they felt better after amalgam 
removal. In the quantitative part of the study, we found significant reductions of index 
scores for intraoral and general health complaints three years after amalgam removal 
(Paper I), and we found that 19 of the 23 investigated health complaints were lower at 
the three-year follow-up than before amalgam removal (Paper II). Reductions of health 
complaints after amalgam removal have also been reported in previous amalgam 
removal studies (Table 1).  
In Paper I, changes in health complaints in the group that had amalgam replaced were 
compared with changes in health complaints in a no-treatment reference group. 
Changes in index scores for intraoral and general health complaints were found to be 
significantly different in the two groups. In the reference group, there was a slight 
increase of index scores from Questionnaire 1 to Questionnaire 3. In Paper II, we 
compared the levels of the 23 investigated health complaints in the treatment group 
with the levels found in an external reference group from the general population. At 
the pre-treatment examination, patients in the treatment group reported a higher level 
of all health complaints than the participants from the external reference group. The 
difference between the treatment group and the external reference group was 
statistically significant for 11 of the 23 complaints. At the three-year follow-up, only 6 
of the 23 health complaints were still significantly higher in the amalgam removal 
group than in the reference group from the general population. Even though the 
reported health complaints were reduced in the amalgam removal group, participants 
in this group still reported higher levels of complaint than the background levels in the 
general populations. Similar findings have been reported in previous studies (Lygre et 
al., 2005; Nerdrum et al., 2004; Tillberg et al., 2005). 
Patients with health complaints attributed to dental amalgam have consistently been 
described as a heterogeneous group (see for instance Langworth et al., 2002; Lindh et 
al., 2002). Even though application of exclusion criteria is likely to have reduced the 
heterogeneity to some degree, our sample can still be described as heterogeneous. 
There was a considerable pre-treatment variation between the participants regarding 
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the number of reported complaints and perceived intensities of complaints, and the 
reported changes in health complaints after amalgam removal also varied greatly 
between participants (Paper II). Unfortunately, the sample was not large enough to 
perform post hoc analyses comparing responders and non-responders to the amalgam 
removal intervention.  
Even though the majority of amalgam removal studies (Table 1) report some kind of 
reductions of health complaints at group level, the understanding of the specific effects 
of amalgam removal remains complex and somewhat elusive. When it comes to 
changes in specific health complaints, normally only some of the reported changes are 
statistically significant, and the health complaints that are significantly reduced may 
vary from study to study. For instance, in our study, mean values for 19 of the 23 
surveyed health complaints were lower at the three years follow-up than at the pre-
treatment examination (Paper II) with statistically significant reductions found for 
“taste disturbances”, “pain from muscles and joints”, “gastrointestinal symptoms”, 
“symptoms from ear, nose and throat”, and “fatigue”. The same questionnaire was 
used in a previous study (Lygre et al., 2005) that investigated changes in health 
complaints after removal of dental restorations (mostly dental amalgam). This study 
found a small reduction of all health complaints except gastrointestinal symptoms. 
However, the reductions were only statistically significant for “taste disturbances”, 
“dry mouth” and “intraoral stiffness/paresthesia”. Comparisons between these studies 
show that “taste disturbances” were significantly reduced in both, whereas 
“gastrointestinal symptoms”, which were significantly reduced in our study, increased 
in the study by Lygre et al. (2005). Some of this elusiveness can of course be 
connected to the predominantly small samples in these studies which increase the risk 
of a Type II-error (i.e. failing to reject the null hypothesis when it is false). However, 
the lack of consistent findings when it comes to changes of the specific symptoms is 
also likely to reflect the heterogeneous character of the complaints, and thus, the effect 
of amalgam removal is likely to be different from patient to patient, and perhaps, due 
to application of different inclusion criteria, the way the studies are carried out, and 
how the health complaints are measured, also from study to study. In the qualitative 
part of the study, we found that most of the participants reported feeling better after 
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amalgam removal (Paper IV) although none of the participants reported a full 
recovery. In an interview study from New Zealand (Jones, 2004) two-thirds of the 
participants who had completed amalgam removal and a detoxification process 
described having obtained a full recovery, and several of the participants referred to 
dental amalgam as a dripping tap that, through amalgam removal, had been turned off. 
5.3.2 Factors influencing the reported reductions of health 
complaints
As discussed under Methodological considerations, even though we have a quasi-
experimental design, the design of our study does not allow us to make strong causal 
inferences. The described limitations of both the quantitative and qualitative parts of 
our study must be kept in mind when interpreting the results. Consequently, the 
following suggestions of factors that can have influenced the reported reductions of 
health complaints have to be considered as hypotheses.
Reduced exposure to mercury: Participants’ in the treatment group had significantly 
lower levels of mercury in serum and urine after removal of dental amalgam (Paper I). 
The mercury levels in the treatment group, however, were low even before the 
amalgam removal, and exploratory analyses of correlations between reduction of 
mercury in serum and reductions in health complaints resulted in only small, and not 
statistically significant, positive correlations. As described in the Introduction, there is 
a lack of scientific support for adverse effects from low-level exposure to mercury. It 
has been claimed, however, that people with typical amalgam exposure could be on 
the threshold to what is considered tolerable daily exposure (Homme et al., 2014), and 
it has been pointed out that there is a need for more research into the effects of genetic 
polymorphism on individual susceptibility to mercury (SCENIHR, 2015b). 
Consequently, reduced exposure to mercury can have contributed to the reduction of 
reported health complaints. However, given the lack of strong support for adverse 
effects of low-level exposure to mercury and the heterogeneity of reported complaints 
and changes in complaints, we also have to consider that the reported reductions of 
health complaints can have been influenced by other elements of the intervention and 
by other changes in the participants’ lives.  
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Improved intraoral conditions after amalgam removal: In paper I, we found that 
index scores for intraoral and general health complaints were significantly reduced 
after replacement of amalgam fillings. Even though participants were excluded if they 
needed a complicated dental rehabilitation, the reported reductions of intraoral index 
scores may have been associated with improved oral conditions after the amalgam 
removal. In Paper I, we concluded that given that the removed amalgam fillings were 
described as sound and well-functioning, it seemed unlikely that an effect of improved 
dental health should be prominent three years after completed amalgam removal. 
However, in the interviews, which were carried out five years after amalgam removal 
(Paper IV), several of the participants described that they felt their oral condition had 
improved after the amalgam removal, indicating that these changes were perceived as 
significant and long-lasting. It was also evident that participants found it easier to 
connect experienced changes in intraoral health complaints with the amalgam removal 
than changes in general health complaints (Paper IV).  
Non specific factors related to the treatment context:As discussed under the heading 
Construct validity it is likely that non-specific factors related to the treatment context 
have influenced the results. Some of these factors, such as elimination of worry, are 
likely to be transferred to other settings, whereas the patient-centered communication 
and the general care associated with the follow-ups are not likely to be associated with 
amalgam removal in the general context. Even though the dentists may be as friendly 
and skilled as the dentists in our study, it is not likely that amalgam removal would be 
associated with an extensive follow-up in addition to the dental treatment. 
5.3.3 Comparisons with other patient groups 
Some of the complaints that amalgam patients report are similar to health complaints 
associated with chronic low-level exposure to mercury (Melchart et al., 2008). The 
reported complaints, however, are also similar to complaints found in groups of 
patients with diagnoses such as fibromyalgia (Clauw, 2009), chronic fatigue syndrome 
(Yancey & Thomas, 2012) and multiple chemical sensitivity (Winder, 2002), as well 
as to complaints found, albeit at lower levels, in the general population (Ihlebæk et al., 
2002). Due to the subjective nature of the complaints and the number of organ systems 
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involved, this is hardly surprising. It does, however, highlight the difficulties related to 
the demarcation of this patient group, and it points us towards situating patients with 
health complaints attributed to dental amalgam within the field of subjective health 
complaints or medically unexplained health complaints.  
Patients with health complaints attributed to dental amalgam are sometimes described, 
particularly by the patients themselves and patient organizations, as suffering from 
amalgam illness, amalgam disease, or amalgam syndrome. Syndrome can be defined 
as: “A group of symptoms which consistently occur together, or a condition 
characterized by a set of associated symptoms” (Oxford Dictionaries, 2016). The 
defining feature of amalgam syndrome is the hypothesized cause of the complaints, 
and amalgam syndrome can as such be compared with other exposure-based 
syndromes, or sensitivity-related illnesses, like multiple chemical sensitivity, 
sensitivity to electromagnetic fields, and food intolerance, which are all characterized 
by patients reporting adverse health effects in relation to low-dose environmental 
triggers (Genuis, 2010). Within the field of subjective health complaints there are also 
a number of symptom-focused syndromes, or central sensitivity syndromes, for 
example chronic fatigue syndrome (CFS), irritable bowel syndrome (IBS) and 
temporomandibular joint disorder (TMJ)(Chinn, Caldwell, & Gritsenko, 2016). Both 
the exposure-based and symptom-focused syndromes are sometimes referred to as 
contested illnesses to delineate that the diagnoses are based on self-reported health 
complaints and that the etiology and demarcation of the syndromes are still unresolved 
(Dumit, 2006; Wainwright, Calnan, O'Neil, Winterbottom, & Watkins, 2006). 
However, recent advances, for instance in conjunction with dietary restrictions for 
patients with IBS (Ahmad & Akbar, 2015; Chey, 2016) and trials with the drug 
Rituximab for patients with CFS (Fluge et al., 2011; Mensah et al., 2015) have pointed 
to possible biological mechanisms associated with some of the experienced complaints 
in these conditions.  
Within the field of subjective health complaints, there are many theories, 
terminologies and labels. However, for both patients and researchers/health personnel 
these can be experienced as lacking authoritative meaning if they are not validated by 
 66
biomedical findings and/or associated with clear prognoses or suggested treatments. 
When they are unable to obtain a diagnosis, or are diagnosed with a contested illness, 
patients can find it difficult to give meaning to their illness experiences, and for many 
patients the search for an answer can become important in itself. The complexities and 
uncertainties we as researchers face when trying to understand what lies behind the 
reported changes in health complaints can steer us towards appreciating how daunting 
the search for an answer can be for the patients themselves.  
5.3.4 Life is complicated-let’s fix it! 
Through participants’ descriptions of trying to live with and make sense of changes in 
health complaints, we identified a tension between acknowledging that health is 
determined by many factors and difficulties related to utilizing such an understanding 
when trying to deal with health complaints in everyday life. 
Patients with health complaints attributed to an exposure such as dental amalgam run 
the risk of being perceived as only accepting and pursuing this one explanation for 
their health complaints, and patients with subjective health complaints are often 
described as dismissive of psychological and social explanations for their complaints 
(Risør, 2009). The findings from our interviews do not support such interpretations for 
our study group, and other studies have also identified complex illness explanations 
held by groups of patients with medically unexplained health complaints and contested 
diagnoses (Risør, 2009; Soderlund & Malterud, 2005) 
The opening phrase of the interviews went something like: “The focus for this 
interview is possible changes in health complaints and quality of life after amalgam 
removal. However, we do know that things in life are connected, so we are interested 
in the big picture.” This wording is of course likely to have set the tone for a 
conversation in which participants were prompted to think of and describe health as 
determined by many factors. The degree to which such aspects were interwoven in the 
participants’ descriptions of both the attribution process and the way they experienced 
changes in health complaints, however, indicates that this is close to how they think of 
their health complaints in their everyday lives.  
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Even though the biopsychosocial model for disease was never specifically mentioned 
by the interviewer or the participants, all participants described having carried out a 
broad exploration of how the different factors in their lives, such as work conditions, 
family obligations, food, stress, worry et cetera could have influenced their health 
complaints both before and after removal of dental amalgam (Paper III and IV). Based 
on participants’ descriptions, a pattern of behavior emerged involving a search for an 
answer, testing of a solution, and evaluation of the effect (Figure 5). In the interviews, 
the participants described this problem-solving sequence in detail in the pursuit of 
dental amalgam as a possible cause of their health complaints. However, participants 
also described having searched for other possible explanations before, in parallel with, 
and after pursuing the amalgam angle, and they also described at length how they had 
made a lot of different changes in their lives such as taking vitamin-supplements, 
changing their work conditions, experimenting with diets et cetera (Paper IV). An 
active search for answers has also been described in other studies of patients with 
medically unexplained health complaints, and the importance of naming (i.e. obtaining 
a diagnosis) is often stressed (Glenton, 2003; Kornelsen et al., 2015; Whitehead, 
2006). In the study by Kornelsen et al. (2015) the search was described as “an 
“emotional rollercoaster” of hope that a diagnosis—and subsequent treatment—would 
be forthcoming” (p. 4).  
 
 68
Figure 5: The pattern of searching for an answer, trying out a solution and evaluating the effect
illustrated with dental amalgam as the explanation being tried out.
Most attribution theories (see for instance Försterling, 1988; Sensky, 1997) assume 
that people are motivated to seek causal explanations for their complaints and that they 
do this through methods similar to the ways scientists determine causality. This seems 
to be a good description for the participants in our sample. In their search for an 
explanation for their health complaints, they considered multiple possibilities, and 
when the search, due to one or more eliciting experiences, pointed in the direction of 
their amalgam fillings, they set out to evaluate whether this seemed to be a reasonable 
explanation for their health complaints. In Paper III, we identified five themes in 
participants’ descriptions of the attribution process. In the first theme “Feeling 
puzzled” participants described that both characteristics of their health complaints, 
such as feeling that their whole body was influenced by something from the outside, 
and the lack of other explanations for their complaints, opened up for thinking that the 
complaints could be connected to their amalgam fillings. In the next three themes, 
 69
“Picking up anecdotal evidence”, “Temporal relationship between dental treatment and 
episodes of ill-health”, and “A trusted person suggested dental amalgam as an 
explanation for my complaints”, participants described different, but not mutually 
exclusive, routes to how they first started thinking of a possible link between their 
health complaints and their amalgam fillings. Other studies have also identified 
experiences of ill-health in relation to dental treatment (Lindh et al., 2002; Norheim & 
Ramstad, 2006; Tillberg et al., 2005), picking up anecdotal evidence (Jones, 2004) and 
suggestions from friends (Jones, 2004) as eliciting factors for forming an amalgam 
attribution. In the fifth theme in Paper III, “Feeling a resonance with descriptions of 
amalgam poisoning”, the initial suspicion was further processed through participants’ 
search for more knowledge and subsequent evaluation of whether this could apply to 
them. The majority of participants described feeling a strong sense of recognition at 
this point, and some described a feeling of relief associated with arriving at an 
amalgam attribution for their health complaints. For some of the participants, thinking 
of their health complaint as being caused by their amalgam fillings gave them hope 
that there might be a cure for their complaints. Consequently they could, for a while, 
stop searching for other explanations.  
Even though some of the participants described letting go of the pursuit of other 
explanations for a while, it can be argued that inflexibility connected to pursuit of 
explanations is a more fitting description of the medical profession’s reactions to 
patients with subjective health complaints. In the interviews, participants described 
how living with and making sense of health complaints that are neither fully accepted 
nor satisfactorily understood by the medical profession took its toll both practically 
and emotionally (Paper IV). The process of trying to identify, or at least hypothesize, 
how interactions between biological, psychological and social variables influence the 
reported complaints, is cognitively taxing. As researchers and health personnel, we can 
easily end up in a far from satisfactory situation by arriving at either all-encompassing 
and useless explanations like “everything connects to everything else” or dismissive 
and equally useless explanations like “if the complaints cannot be objectively 
identified, there is no (somatic) pathology”. Common to both is the lack of a 
reasonable next step. In contrast to these non-actionable explanations, it is not hard to 
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understand that interactions or possible causes that in some way stand out can prompt 
patients to arrive at actionable, but limited, attributions. It is not difficult to understand 
the appeal of an explanation where one factor, such as the presence of amalgam 
fillings, could potentially explain the majority–or all–of the complaints for which the 
health profession has failed to find explanations. In addition to its simplicity, it also 
points towards a very concrete and implementable, albeit expensive, solution, namely 
amalgam removal. 
As previously mentioned, both folk models and the models used by the medical and 
dental profession, easily revert to a biomedical understanding of disease where the 
way forward is dependent on objective findings pointing us towards a diagnosis. 
However, for people with subjective health complaints, a diagnosis is not always 
within reach, or if diagnosed with a contested illness, the patient might associate the 
diagnosis with almost as many unknowns as he/she had to face before being diagnosed 
(Kornelsen et al., 2015). Perhaps some of the emotional tug of the biomedical model is 
connected to the simplicity of thinking of disease as something concrete that can be 
controlled and attacked? In the words of Engel (1960): 
To be able to think of disease as an entity, separate from man and caused by an 
identifiable substance, apparently has great appeal to human mind. Patients 
prefer to blame their illness on something they “caught” or ate, or that happened 
to them, and to think of disease as something apart. Physicians also find such 
ways of thinking attractive, particularly if they can see the “cause” of the 
disease as something which they can attack and destroy. (p. 48)
For patients with subjective health complaints such a conceptualization, however, is 
far from their everyday experiences. Given the lack of answers associated with 
subjective health complaints, it can be difficult for patients to know where to direct 
their energy. Is their energy best spent searching for an explanation and thereby 
hopefully also a cure? On the other hand, is it better to spend energy on trying to adapt 
to and live with the health complaints? Juxtaposed with the sheer number of 
interactions one potentially has to consider within a biopsychosocial framework, the 
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allure of more simple and actionable conceptualizations, such as an amalgam 
attribution or a non-contested diagnosis, is not difficult to understand.  
5.3.5 Finding meaning  
However, to look at subjective health complaints merely as problems that can be fully 
solved or fully understood if only one spends enough time, money and brain power on 
it, either at macro level (e.g. research efforts) or at micro level ( i.e. each individual’s 
quest for a solution), could lead us to miss important parts of the puzzle. When faced 
with health complaints, both explained and unexplained, patients often experience the 
need to find meaning in their complaints. For patients with unexplained health 
complaints, this process can be hindered, and sometimes even “railroaded”, by the 
search for a diagnosis. 
In paper IV, we used Cassel’s (1982) definition of suffering: “suffering occurs when 
an impending destruction of the person is perceived; it continues until the threat of the 
integration has passed or until the integrity of the person can be restored in some other 
manner” (p. 640). In this lies an important distinction between pain/health complaints 
and the suffering associated with them. Health complaints that are interpreted as 
signifying “impending destruction”, for instance through threating participants’ life 
span, relationships and/or perception of self, are associated with more suffering than 
health complaints that are interpreted as transient or controllable. Health complaints 
with unknown prognoses are likely to cause more suffering than equally severe health 
complaints where one is expected to make a full recovery within a reasonable time 
frame. Consequently, it is not difficult to understand that the lack of answers 
associated with subjective health complaints can lead to increased suffering. When so 
much is unknown, it is hard to evaluate the severity and the probability of “the 
impending destruction”, and the necessary steps either to fend off the destruction or to 
find some other way to “restore the integrity of the person” may not be readily seen. 
This puts an extra pressure on both patients and health personnel. However, as also 
discussed in Paper IV, in the context of medical encounters, patients and health 
personnel mostly focus on the pain or the health complaint in question and not on the 
suffering associated with it (Loeser, 2000).  
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When a resolution of the complaints cannot be obtained through standard diagnostic 
procedures, both patients and health personnel may react with frustration and the 
quality of communication can deteriorate. In Paper IV, participants’ described feeling 
left to their own devices when physicians were unable to explain their health 
complaints. The importance of having someone with whom they could discuss their 
health complaints was pointed to by several of the participants. Some of them 
described having a close relationship with practitioners of alternative medicine, and 
most of the participants described that they had really appreciated the follow-up they 
had received from the personnel at the Adverse Reaction Unit during the trial. Some of 
the perceived benefits are probably related to patients being seen and heard. However, 
it is also likely that to have someone with whom to discuss perceived health 
complaints and potential consequences of the health complaints, can result in assuaged 
worries and increased confidence in being able to manage one’s health complaints.  
In our material, participants’ suffering was perhaps most strongly communicated when 
they described their feelings of not being able to perform as well as others because of 
their health complaints. From an outsider’s perspective, the participants’ descriptions 
of what they managed to do despite their health complaints were impressive. The 
participants themselves, however, did not seem to share this view. Instead they pointed 
to a number of activities and obligations they were not able to participate in or carry 
out as they wanted. Several expressed sadness at not being able to perform as 
effortlessly as people without health restraints. With the exception of wanting to be a 
better parent, spouse et cetera, many of the activities they said they were unable to 
carry out (such as participating in social activities at work, meeting friends and 
acquaintances, etc.) could easily have been deprioritized by people without similar 
health complaints. Nevertheless, not being able to carry out these activities seemed to 
have almost symbolical value for some of the participants. This is probably related to 
participants’ feeling that they did not have a choice when they had to drop 
participation in these activities. However, the discord between facing challenges and 
obligations with energy and drive, as we also touched upon in Paper IV, and having to 
say no to participating in activities may also partly explain the participants’ sadness 
and frustration. When describing these situations, and the differences between 
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themselves and people without similar health complaints, a threat to the person’s 
integrity could be felt, and the uncertainties related to prognosis seemed to accentuate 
their suffering.  
Participants also seemed to grapple with where they should direct their energy: Should 
they continue their search for other explanations or should they consider their health 
complaints as something to be expected and as a part of their everyday life? Some of 
the participants expressed relief, but also resignation, in terms of relaxing their efforts 
to find an answer. Several of the participants acknowledged that the search for an 
explanation and/or effective treatment strategies had been time consuming and 
exhausting, and they saw clear benefits in easing up on their efforts and instead 
focusing on enjoying the best life possible despite their health complaints. For several 
of the participants, however, it seemed important that they had pursued many different 
potential explanations, and thereby had truly made an attempt to get better. For several 
of the participants, the amalgam removal was described as a necessary step towards 
accepting their health complaints. Without the removal, they suspected that they would 
always have had a lingering suspicion that their health complaints were associated 
with their amalgam fillings. 
We believe that it is important to find a way of routinely addressing the effects that 
patients’ health complaints have on their everyday lives and their hopes and fears for 
the future. Through staying close to patients’ experiences of their health complaints, 
the suffering related to the health complaints and the way the health complaints 
influence their everyday life, we believe health personnel can gain important insight 
into patients’ experiences, and hopefully, patients will be enabled to find an arena for 
creating meaning of their illness experiences. For patients with subjective health 
complaints, the importance of having a good patient-physician relationship with room 
for exploration of patients’ experiences has been repeatedly described (see for instance 
Kornelsen et al., 2015; Peters et al., 2009). When relevant medical examinations have 
been carried out, it is important that both health personnel and patients acknowledge 
that even though it is not always possible to find the answers, or even to agree on the 
probable cause of the complaints, many patients will nevertheless still need help to 
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find ways of living with their health complaints. In a biopsychosocial perspective, 
there should be many ways to address this and hopefully also to ease the burden for 
patients. However, if the patients believe that a likely effective treatment, such as 
amalgam removal, is within reach, it is likely that other approaches seem deficient and 




The participants reported reduced levels of health complaints after amalgam removal. 
Analyses of mercury concentration showed that mercury levels in serum and urine 
were significantly reduced after amalgam removal. The mechanisms behind the 
reported reductions in health complaints are probably compounded, however, and not 
limited to the reduced exposure to mercury. This was also acknowledged and 
underscored by the participants in the interview study, and their experiences of 
changes in health complaints after amalgam removal can be summarized by the 
statement “It was certainly important to get rid of the amalgam, but it is uncertain how 
important the removal was for the experienced changes in health complaints.” 
Different explanations for the reported changes in health complaints were suggested, 
including non-specific treatment effects associated with the interventions. This is 
important to keep in mind when estimating the effects of amalgam removal on health 
complaints in a regular treatment context or if designing future amalgam removal 
studies. The effects of the amalgam removal, particularly related to participants feeling 
better, which was evident both in the quantitative and qualitative part of our study, 
should not be dismissed, however. Similar findings have also been reported in 
previous studies (Table 1). In the interviews, several participants emphasized the 
importance of amalgam removal for moving towards an acceptance of health 
complaints as part of life, and regardless of perceived health effects of the amalgam 
removal all participants expressed relief in having had all their amalgam fillings 
removed.  
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7. Future perspectives 
When maneuvering a field with a lack of definite answers and diagnoses, it is 
important to make room for addressing the suffering associated with pain, health 
complaints and illness experiences in medical encounters. If we, as researchers and 
health personnel, take the time to listen to patients’ explanations for their health 
complaints and their fears associated with them, we can better understand and 
hopefully also help. We may also find that patients’ explanations are far more complex 
than what we normally catch on to within the short and, often tightly scripted, medical 
and dental encounters that normally take place. In addition to making sure that the 
patients receive appropriate and exhaustive medical and dental examinations, we 
should, together with the patients, explore the different ways social and psychological 
factors interact with the experienced health complaints.  
 
In our encounters, we should also take in that reassurances such as “dental amalgam is 
considered a safe treatment alternative at group level” could have limited value for 
patients who suspect that this does not hold true for them. We should also take in that 
our study and other studies such as the studies described in Table 1, find that patients 
report improved health after replacement of amalgam fillings. Even though the 
mechanisms behind this are most likely compounded and not limited to the reduced 
exposure to mercury, the fact that we do not fully understand the reasons for the 
reported reductions of health complaints is perhaps of greater concern for researchers 
and health personnel than for the patients themselves. Patients who still fear their 
health complaints are caused by their amalgam fillings after having had the chance to 
discuss their concern with health personnel who possess updated knowledge and have 
the time and motivation to listen to the patients, should be given the opportunity to 
have their amalgam fillings removed at a cost they can afford. However, other causes 
for the health complaints must be properly investigated and excluded before initiating 
amalgam removal and the risk associated with removing sound fillings must be 
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SUMMARY The aim of the present study was to
investigate whether removal of all amalgam fillings
was associated with long-term changes in health
complaints in a group of patients who attributed
subjective health complaints to amalgam fillings.
Patients previously examined at the Norwegian
Dental Biomaterials Adverse Reaction Unit were
included in the study and assigned to a treatment
group (n = 20) and a reference group (n = 20). Par-
ticipants in the treatment group had all amalgam
fillings replaced with other restorative materials.
Follow-ups took place 3 months, 1 and 3 years after
removal of all amalgam fillings. There was no
intervention in the reference group. Subjective
health complaints were measured by numeric rating
scales in both groups. Analysis of covariance was
used to compare changes in health complaints over
time in the two groups. In the treatment group,
there were significant reductions in intra-oral and
general health complaints from inclusion into study
to the 3-year follow-up. In the reference group,
changes in the same period were not significant.
Comparisons between the groups showed that
reductions in intra-oral and general health com-
plaints in the treatment group were significantly
different from the changes in the reference group.
The mechanisms behind this remain to be identified.
Reduced exposure to dental amalgam, patient-
centred treatment and follow-ups, and elimination
of worry are factors that may have influenced the
results.
KEYWORDS: health complaints, amalgam, before-and-
after study, dental, restoration
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Introduction
For decades, dental amalgam has been extensively
used in the treatment of caries lesions. Dental amal-
gam consists of approximately 50% metallic mercury
mixed with an alloy mainly consisting of silver, tin
and copper (1). The safety of dental amalgam has
been questioned, and it has been discussed to what
extent mercury released from amalgam fillings may
lead to adverse health effects (2–8). Generally, no
deleterious effects from amalgam are detected in
studies on samples of the general population (5,
9–11), and no adverse reactions could be detected in
two randomised controlled studies on school children
treated with dental amalgam (3, 4). Dental amalgam
fillings release elemental mercury vapour in the
mouth, resulting in elevated concentrations of mer-
cury in blood, plasma and urine, and concentration of
inorganic mercury in the brain (12–19). The possibility
that a small fraction of the population may have
predispositions to rare adverse reactions to dental
amalgam cannot be ruled out; thus, research on
adverse effects associated with exposure to dental
amalgam should focus on the possibility of rare
outcomes (20). People with health complaints
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attributed to dental amalgam believe their health
complaints are caused, or aggravated, by mercury
released from their amalgam fillings. It has been estab-
lished that dental amalgam fillings may lead to local
adverse reactions, including oral lichenoid reactions
(21), and removal of amalgam fillings in contact with
the lesions is generally recommended. However, for a
number of patients, no objective signs of adverse
reactions to amalgam fillings, or other diseases explain-
ing their complaints, can be observed (22). Patients who
attribute subjective health complaints to dental amal-
gam describe a number of health complaints including
tiredness, headaches, pain from muscles and joints, and
problems with memory and concentration (18, 22).
There is a lack of treatment options for patients without
objective signs of adverse reactions to amalgam fillings,
and removal of sound amalgam fillings is generally not
recommended. Some patients nevertheless decide to
remove all amalgam fillings at their own initiative (23),
and studies have reported significant improvements
in subjective health complaints after the removal of
amalgam fillings (24, 25).
The aim of the present study was to investigate
whether removal of all amalgam fillings in a group of
patients who attributed subjective health complaints to
dental amalgam (treatment group) was associated with
long-lasting changes in subjective health complaints.
The underlying null hypothesis was that there would be
no significant differences in long-term changes in health
complaints between the treatment group and a compa-
rable reference group. In addition, secondary analyses of
changes in health complaints in the treatment group
and the reference group were investigated indepen-
dently, testing the null hypotheses of no changes in
health complaints within each group. Within-group
changes in mercury concentration in serum and urine in
the treatment group were also investigated.
Materials and methods
Design
The study was designed as a before-and-after study
with a comparison group (reference group) comparing
changes in health complaints in a treatment group,
which had all amalgam fillings replaced with other
restorative materials, with changes in health complaints
in a comparable reference group, which did not receive
any intervention.
Participants
Participants were recruited from patients (n = 368)
examined at the Norwegian Dental Biomaterials
Adverse Reaction Unit in the period 1993–1999 (initial
examination; Fig. 1). The majority of the patients had
been referred to the unit because of health complaints
attributed to amalgam fillings (22). Generally, either
the patient or the referring physician ⁄dentist had raised
the question that dental materials could be a causal or
contributing factor related to the patient’s health
problems. In 2000–2001, patients with known
addresses (n = 358) were sent a questionnaire (Ques-
tionnaire 1) regarding current health complaints and
medical and dental treatment since the initial exami-
nation. The questionnaire was returned by 207 patients
(Fig. 1). Based on the responses to the questionnaire,
157 patients did not fulfil one or more of the inclusion
criteria listed in Table 1, leaving 50 patients who were
randomly allocated into a treatment group (n = 20), a
reference group (n = 20) and a group of reserves
(n = 10; Fig. 1). The function random number in
Microsoft Excel 97 was used for the allocation. The
exclusion criteria listed in Table 1 were applied to the
treatment group in order to increase the probability of
participants in this group being able to complete the
replacement process. Six participants were excluded
from the treatment group according to these criteria.
The same exclusion criteria were used in the group of
reserves for sequential inclusion into the treatment
group, resulting in four participants not being eligible
for participation in the treatment group. The remaining
six participants from the group of reserves were used to
replace the excluded participants from the treatment
group. The criteria were applied based on clinical
documentation, telephone interviews and a clinical
examination (pre-treatment examination). The exclu-
sion criteria were initially not applied to the reference
group as no intervention was planned for this group.
Initial examination (1993–1999)
At the initial examination at the unit (22), patients
underwent a medical and dental examination. Blood
and urine samples were collected and analysed for
mercury in addition to routine analyses (17). Patients
were also asked to complete questionnaires regarding
suspected adverse reactions to dental materials, current
and previous health complaints and demographic
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variables. Participants included in the present study had
at the initial examination neither signs of contact
allergic reactions to dental materials nor a known
history of such reactions and consequently were not
recommended removal of amalgam fillings.
Questionnaire 1 (2000–2001)
Questionnaire 1 included questions regarding current
health complaints, treatment since the initial examina-
tion and demographic variables. Health complaints
were measured by numeric rating scales using numbers
from 0 to 10. No information on a planned intervention
study was given in the questionnaire. Responses to
Questionnaire 1 were used for identifying patients
eligible for participation and as baseline values for
comparisons of changes in health complaints in the
treatment group and the reference group. Questions
from Questionnaire 1 were included in all subsequent
questionnaires.
Initial examination (1993–1999)
n = 368 
Questionnaire 1 (2000–2001)
n = 358 a
Not included
n = 157 b
Analysed for changes in health complaints
from Questionnaire 1 to 3 year follow-up:
n = 19












Responded to Questionnaire 1
n = 207 
Analysed for changes in health complaints 
from Questionnaire 1 to Questionnaire 3: 
n = 13
Analysed for changes over time:
n = 12
Excluded c 
n = 10 
Treatment group
n = 20 
Lost to follow-up:
3 months: n = 1
1 year: n = 0
3 years: n = 1
Responded to:
Questionnaire 2: n = 15
Questionnaire 3: n = 15
Lost to follow-up:
Questionnaire 2: n = 5
Questionnaire 3: n = 5
Excluded from analyses d:
Questionnaire 2: n = 1




3 months: n = 19
1 year: n = 20




Fig. 1. Participant flow. Flow diagram showing participant flow in the study. The study is a before-and-after study with a comparison
group (reference group). aCurrent addresses were missing for 10 patients; bdid not fulfil inclusion criteria listed in Table 1; cexcluded
according to exclusion criteria listed in Table 1; dremoved all amalgam fillings.
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Pre-treatment examination
In September 2002, participants in the treatment group
underwent a pre-treatment examination consisting of
medical and dental examinations and collection of
samples of blood serum and urine. Blood serum was
analysed for mercury concentration by sector field
inductively coupled plasma–mass spectrometry (26,
27), while urine was analysed for mercury concentra-
tion by cold vapour atomic absorption spectrometry
(28). Participants also responded to a questionnaire
similar to Questionnaire 1. The pre-treatment exami-
nation and all subsequent follow-ups took place at the
Dental Biomaterials Adverse Reaction Unit. Participants
in the reference group were not assigned any treatment
and were not asked to go through a pre-treatment
examination.
Intervention
The assigned intervention in the treatment group was
removal of all amalgam fillings. The amalgam fillings
were replaced with other dental restorative materials
(e.g. composites, ceramic restorations and metalloce-
ramic crowns). All treatment costs were covered by
project funds. Replacement of amalgam fillings is not
possible to mask, and thus, no blinding was used. The
replacement was carried out by the participants’ own
dentists according to clinical guidelines aiming at
minimal exposure to mercury during removal sessions
(29). The dentists were instructed to use rubber dam,
high-volume suction, water cooling and to remove
fillings in chunks using a sharp dental bur. Eighteen
dentists from 18 different dental practices were in-
volved in the study. One dentist treated three patients;
the other dentists treated one patient each. Participants
were given written instructions to contact the Dental
Biomaterials Adverse Reaction Unit if they experienced
increased health complaints like chills, fever, pain and
rashes in relation to the amalgam replacement process.
These instructions included advice to the patient’s
physician regarding blood tests to be taken (leucocytes,
CRP, IgE and mercury concentration in blood) in case
of increased health complaints after dental treatment.
To compare replacement of amalgam fillings with the
standard treatment (i.e. no amalgam replacement), no
intervention was assigned to the reference group.
Follow-up
Treatment group. Routines for the follow-ups were
similar to the pre-treatment examination. Follow-ups
took place 3 months, 1 and 3 years after completed
replacement of amalgam fillings (Fig. 2). The follow-
ups included control of the new dental restorations by a
dentist, questions about experienced side effects like
post-operative dental pain and other complications, and
collection of serum samples. Urine samples were
Table 1. Eligibility criteria and number of patients not included.
Inclusion criteria were applied based on information from initial
examination and Questionnaire 1. Exclusion criteria were applied
in the treatment group and reserves, and were applied in relation





Referred to the Norwegian Dental
Biomaterials Adverse Reaction Unit
for examination of health
complaints attributed to amalgam
fillings
33
Amalgam fillings still present 79
No diagnosed contact allergy to
substances in resin-based dental
materials
54
Health complaints from at least three
different organ systems
25
Data on mercury in blood and urine
from initial examination
59
Age 25–55 at initial examination 10
Accepted to be contacted in a
follow-up study
11




Severe medical disorders (e.g.
multiple sclerosis, ALS, severe
rheumatoid arthritis)
1
Severe food allergies 1
Psychological difficulties or
psychiatric disorders that could
influence the dental treatment
3
Complicated therapy (severe
periodontitis, high caries activity
and ⁄ or need for complicated dental
rehabilitation – e.g. bridges)
4
Inclusion criteria no longer fulfilled 1‡
†One hundred and fifty-seven patients did not fulfil one or more
of the inclusion criteria.
‡Completed removal of amalgam fillings since responding to
Questionnaire 1.
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collected at follow-up after 1 year. No general medical
interview or health guidance was included.
Reference group. Follow-ups in this group were limited
to questionnaires sent by post. Participants were sent
Questionnaire 2 in 2004 and Questionnaire 3 in 2007.
Questionnaire 2 was given at approximately the same
time as the majority of participants in the treatment
group went through their 1-year follow-up. Question-
naire 3 was given in parallel with the 3-year follow-up
in the treatment group (Fig. 2). Based on available
information from the initial examination and Ques-
tionnaire 1, the exclusion criteria used in the treatment
group were applied post hoc to the reference group,
resulting in two of the initial 20 participants being
excluded. Reasons for exclusion were severe food
allergy and complicated dental treatment (one patient)
and diagnosed contact allergy to substances in resin-
based dental materials (one patient). Results from
comparisons of changes in health complaints in the
treatment group and the reference group were calcu-
lated using both the initial reference group and the
reference group with the two participants excluded
from analyses.
Outcome variables
Primary outcome measures were changes in local oro-
facial complaints and general health complaints from
Questionnaire 1 (inclusion into study) to the 3-year
follow-up in the treatment group and to Questionnaire
3 in the reference group. Current health complaints in
both groups were measured by numeric rating scales
(30) included in the questionnaires. The questionnaires
were given at all measure points. The same scales have
previously been used in a similar patient population (8)
and include 23 items addressing a diverse range of
oro-facial and general health complaints frequently
reported by patients with subjective health complaints
attributed to amalgam fillings. Oro-facial complaints
were categorised as either intra-oral (six items: intra-
oral burning sensation, intra-oral pain ⁄ tenderness,
taste disturbances, intra-oral stiffness ⁄paresthesia, dry
mouth and increased salivation ⁄mucus) or extra-oral
(five items: extra-oral burning sensation, extra-oral
pain ⁄ tenderness, extra-oral stiffness ⁄paresthesia, extra-
oral skin problems and pain from temporomandibular
joints). The sum scores for each category were used as
index scores (8). Index scores for general health
complaints (12 items: musculoskeletal complaints, gas-
trointestinal complaints, cardiovascular complaints,
skin problems, complaints related to eyes ⁄ sight, com-
plaints related to ears ⁄hearing ⁄nose ⁄ throat, tiredness,
dizziness, headaches, memory problems, difficulty con-
centrating and anxiety ⁄depression) were constructed in
the same way (8). Highest possible index score was 60
for intra-oral index, 50 for extra-oral index and 120 for
the general health complaints index. Internal consis-
tency for the indices was estimated by Cronbach’s alpha
using the entire group of patients randomised (n = 50;
Fig. 1) and found to be 0Æ66, 0Æ72 and 0Æ80, respectively.
Power calculation
Number of participants included in this study was
limited by available patients. One of the main objectives
of the study was to test the null hypothesis that changes






















2002 2002–2005 2003–2005 2004–2006 2006–2008
Fig. 2. Timeline for the study. Timeline for the trial for the treatment group and the reference group. Q1, Q2 and Q3 indicate
Questionnaire 1, Questionnaire 2 and Questionnaire 3, respectively. Time frames for the activities are indicated for the treatment group
(top) and the reference group (bottom).
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treatment group and in the reference group. Assuming
a mean difference in index score for general health
complaints of 10Æ0 between the groups (corresponding
to a mean difference before–after of 10Æ0 in the
treatment group versus a mean difference of 0Æ0 in
the reference group) and a common within-group
standard deviation of 10Æ0, a sample size of 20 patients
in each group will give the study a power of 87% to
yield a statistically significant result. The criterion for
significance (alpha) was 0Æ05, and the test was two-
tailed.
Statistical methods
Mean values with 95% confidence intervals and anal-
ysis of variance were used for comparisons between
groups. Paired-sample t-tests and analysis of variance
for repeated measures were used to investigate within-
group changes over time. Variables for changes in
health complaints, from Questionnaire 1 to the 3-year
follow-up in the treatment group and from Question-
naire 1 to Questionnaire 3 in the reference group, were
constructed by subtracting the most recent scores from
the scores from Questionnaire 1. A positive value
indicated a reduction in complaints, whereas a negative
value indicated increased complaints. The primary
hypothesis of changes in reported health complaints
in the treatment group compared with the reference
group was tested by between-group comparisons of
unadjusted pre–post per-protocol changes in the two
groups using independent-sample t-tests. Adjustments
for age, gender, and complaint intensity reported in
Questionnaire 1 were made by analysis of covariance.
We used last value carried forward to replace missing
values for intention-to-treat analysis (ITT). Sample-
Power 2.0* was used for power calculations, and SPSS
15.0* was used for all other statistical analyses. P-values
<0Æ05 were considered statistically significant for all
analyses.
Ethical approval and registration
The project protocol was approved by the Regional
Committee for Medical Research Ethics in Western
Norway (REK III, 24.01) and registered at ClinicalTri-
als.gov (NCT00346944). Participants in the treatment
group received information on possible side effects from
new fillings and possible post-operative complications
following replacement of amalgam fillings. Written
consent was obtained from all participants in both
groups.
Results
Participant flow and numbers analysed
Treatment group. All 20 participants in the treatment
group received the assigned intervention (replacement
of all amalgam fillings). One participant could not
attend the 3-month follow-up, and another participant
could not attend the 3-year follow-up. For analysis of
changes in health complaints from Questionnaire 1 to
the 3-year follow-up, data from 19 participants were
analysed (Fig. 1). For repeated measures analysis, data
from 18 participants were analysed (Fig. 1).
Reference group. Questionnaire 2, which was sent to all
20 participants in the reference group in 2004, was
returned by 15 participants. One participant reported
having removed all amalgam fillings between Ques-
tionnaire 1 and Questionnaire 2. Questionnaire 3 was
sent to all 20 participants in the reference group. The
questionnaire was returned by 15 participants (Fig. 1).
For analyses of changes in health complaints from
Questionnaire 1 to Questionnaire 3, data from 13
participants were analysed. For repeated measures
analysis, data from 12 participants were analysed.
Changes in health complaints in the treatment group
were also compared with changes in the reference
group after post hoc application of exclusion criteria
based on data from 12 participants in the reference
group.
Initial examination and Questionnaire 1
Data from the initial examination and Questionnaire 1
were used as baseline values in the study. Number of
amalgam surfaces and concentration of mercury in
blood and urine were not significantly different
between the groups at the initial examination
(Table 2). Results from Questionnaire 1 showed that
the final treatment group (n = 20) was similar to the
reference group (n = 20) with regard to age, gender
distribution, education level and medication. Levels of
reported intra-oral, extra-oral and general health com-
plaints were slightly lower in the treatment group, but*SPSS Inc., Chicago, IL, USA.
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the differences between the groups were not statisti-
cally significant. The proportion of individuals currently
on sick leave or receiving disability pension was
considerably higher in the group of individuals who
were excluded from the treatment group compared to
the treatment group and the reference group. Partici-
pants’ assessments of risks associated with dental
amalgam were similar across groups (Table 2).
Comparisons of changes in health complaints in the treatment
group and the reference group
Per-protocol comparisons of changes in health com-
plaints, from Questionnaire 1 to the 3-year follow-up in
the treatment group and Questionnaire 3 in the
reference group, showed that changes in mean index
scores for intra-oral and general health complaints were
significantly different in the two groups, whereas
changes in extra-oral health complaints were not
significantly different (Table 3). After adjusting for
gender, age and complaint intensity reported in Ques-
tionnaire 1, changes in intra-oral and general health
complaints remained significantly different, and
changes in extra-oral health complaints remained not
significantly different (Table 3). Results from intention-
to-treat comparisons were in general similar to the
results from per-protocol analyses (Table 3). Results
from analyses based on data from the reference group
after post hoc application of exclusion criteria showed no
major differences compared with the analyses using all
13 participants from the initial reference group. Unad-
justed per-protocol differences in changes in index
scores between the treatment group and the reference
group after application of exclusion criteria were 8Æ3
(95% CI: 1Æ2 to 15Æ3, P = 0Æ024), 3Æ6 (95% CI: )3Æ7 to
10Æ7, P = 0Æ320) and 19Æ9 (95% CI: 8Æ1 to 31Æ7, P =
0Æ002) for the intra-oral, extra-oral and general indices,
respectively.
Table 2. Descriptive background data. Background data for the treatment group, the reference group and for patients excluded from the









group (n = 10) Data from
Women, n (%) 14 (70) 16 (80) 8 (80)
Age (years) in September 2000, mean (s.d.) 46Æ9 (6Æ7) 44Æ7 (6Æ5) 52Æ6 (7Æ0)
Education (years), mean (s.d.) 11Æ5 (3Æ6) 11Æ3 (2Æ8) 10Æ3 (2Æ6) Initial ex.
Reported smoking at initial examination, n (%) 4 (20) 7 (35) 3 (30) Initial ex.
On sick leave or disability pension, n (%) 9 (45) 7 (35) 9 (90) Q1
Regular dental care, n ⁄ valid n† (%) 17 ⁄ 18 (94) 20 ⁄ 20 (100) 6 ⁄ 7 (86) Q1
Used medication last 12 months, n (%)
Analgesics 13 (65) 13 (65) 7 (70) Q1
Antidepressants 6 (30) 3 (15) 2 (20)
Vitamins ⁄ dietary supplements 13 (65) 13 (65) 8 (80)
Participants’ assessments of risks associated with dental amalgam, n (%)
Very high 17 (85) 15 (75) 10 (100) Q1
Medium 3 (15) 4 (20) –
Low – – –
Very low – – –
Missing – 1 (5) –
Number of amalgam surfaces, mean (s.d.) 36Æ8 (11Æ1) 38Æ0 (11Æ3) 27Æ2 (16Æ3) Initial ex.
Concentration of mercury, mean (s.d.)
Blood (nmol L)1) 23Æ5 (10Æ4) 27Æ5 (12Æ5) 33Æ0 (22Æ1) Initial ex.
Urine (nmol L)1) 24Æ0 (17Æ6) 22Æ0 (16Æ4) 21Æ0 (19Æ7)
Urine (nmol per mmol creatinine) 2Æ7 (1Æ9) 2Æ6 (2Æ7) 2Æ4 (2Æ3)
Self-reported health complaints, mean (s.d.)
Intra-oral index 8Æ4 (6Æ6) 13Æ0 (12Æ0) 11Æ2 (7Æ2) Q1
Extra-oral index 6Æ9 (8Æ4) 11Æ0 (9Æ3) 9Æ2 (8Æ0)
General index 41Æ5 (16Æ0) 47Æ3 (21Æ2) 42Æ3 (15Æ0)
†Five patients did not answer the question but had started removal of amalgam restorations.
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Changes in health complaints in the treatment group
In the treatment group, there were significant reduc-
tions in mean index scores for intra-oral and general
health complaints from Questionnaire 1 to the 3-year
follow-up (Table 3). The reduction in mean index
scores for extra-oral health complaints in this period
was not significant. Intention-to-treat analysis showed
similar results as the per-protocol analysis (Table 3). In
the repeated measures analysis (Table 4), data from the
pre-treatment examination and all follow-ups were
included. Per-protocol repeated measures analysis
showed significant overall effects of time for all three
index scores. Plots of intra-oral, extra-oral and general
index scores from Questionnaire 1 against index scores
at 3-year follow-up are given in Fig. 3.
Changes in health complaints in the reference group
In the reference group, there was a slight, but not
statistically significant, increase in mean index scores
for intra-oral, extra-oral and general health complaints
from Questionnaire 1 to Questionnaire 3 (Table 3).
Intention-to-treat analysis showed no significant
changes in mean index scores from Questionnaire 1
to Questionnaire 3 (Table 3). Data from Questionnaire
2 were included in the repeated measures analysis
(Table 4). Per-protocol analysis of changes in mean
index scores over time showed a significant overall
effect of time for general health complaints. Plots of
intra-oral, extra-oral and general index scores from
Questionnaire 1 against index scores from Question-
naire 3 are given in Fig. 3.
Table 3. Comparisons of changes in health complaints in the treatment group and the reference group. Per-protocol (PP) and intention-
to-treat (ITT) comparisons of changes in health complaints from Questionnaire 1 to the 3-year follow-up in the treatment group and
Questionnaire 3 in the reference group. Mean changes in index scores and mean differences in changes in index scores (mean changes in






changes in index scores‡
Adjusted difference in changes in
index scores§
Mean¶ 95% CI Mean 95% CI P-value* Mean 95% CI P-value*
Intra-oral index
Treatment group (PP) 19 3Æ7 0Æ5 to 6Æ9
Reference group (PP) 13 )4Æ2 )11Æ6 to 3Æ1
Treatment–reference (PP) 7Æ9 1Æ1 to 14Æ7 0Æ024 8Æ1 1Æ9 to 14Æ2 0Æ012
Treatment group (ITT) 20 3Æ5 0Æ4 to 6Æ6
Reference group (ITT) 20 )0Æ6 )6Æ4 to 5Æ2
Treatment–reference (ITT) 4Æ1 )2Æ3 to 10Æ5 0Æ200 6Æ9 1Æ3 to 12Æ4 0Æ016
Extra-oral index
Treatment group (PP) 19 1Æ5 )2Æ8 to 5Æ8
Reference group (PP) 13 )1Æ8 )7Æ9 to 4Æ3
Treatment–reference (PP) 3Æ2 )3Æ7 to 10Æ2 0Æ346 5Æ5 )0Æ4 to 11Æ4 0Æ066
Treatment group (ITT) 20 2Æ0 )2Æ2 to 6Æ2
Reference group (ITT) 20 )0Æ6 )4Æ8 to 3Æ6
Treatment–reference (ITT) 2Æ6 )3Æ1 to 8Æ3 0Æ365 4Æ3 )1Æ6 to 10Æ3 0Æ145
General index
Treatment group (PP) 19 9Æ7 4Æ4 to 15Æ0
Reference group (PP) 13 )8Æ7 )21Æ4 to 4Æ0
Treatment–reference (PP) 18Æ4 6Æ8 to 30Æ0 0Æ003 17Æ4 5Æ8 to 29Æ0 0Æ005
Treatment group (ITT) 20 10Æ1 5Æ0 to 15Æ2
Reference group (ITT) 20 )2Æ3 )13Æ1 to 8Æ5
Treatment–reference (ITT) 12Æ4 0Æ9 to 23Æ9 0Æ036 14Æ2 2Æ4 to 26Æ0 0Æ020
*Level of significance: P < 0Æ05.
†For the reference group, data from Questionnaire 3 were used.
‡Independent-sample t-test comparing changes in index scores in the treatment group and the reference group.
§Analysis of covariance of changes in index scores in the treatment group and the reference group, adjusted for gender, age and health
complaints from Questionnaire 1.
¶Positive values indicate reduced health complaints, and negative values indicate increased health complaints.
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Mercury concentration in serum and urine
There was a significant decrease in mercury concentra-
tion in serum and urine following the removal of
amalgam fillings. After removal of the fillings, the mean
serum concentration was reduced to half the concen-
tration at pre-treatment, and the mean concentration
in urine was reduced to about one-fourth of the pre-
treatment concentration (Fig. 4).
Changes in health complaints related to changes in mercury
concentration in serum
Secondary explorative analyses of correlations between
reduction in mercury in serum and reduction in health
complaints 3 years after treatment showed positive but
not significant correlations. Pearson correlation coeffi-
cients were 0Æ320, 0Æ193 and 0Æ127 for correlations
between reduction in mercury in serum and reduction
in intra-oral, extra-oral and general indices, respec-
tively. Corresponding P-values were 0Æ182, 0Æ428 and
0Æ604 (n = 19), leaving no statistically significant sup-
port for mercury as a cause of the complaints.
Adverse events
Seven participants in the treatment group experienced
increased health complaints in connection with
removal of amalgam fillings. Laboratory tests of blood
samples collected within a few days after the treatment
session showed values within reference intervals.
Health complaints reported in connection with amal-
gam removal were gastric pain, pain in joints and
muscles, oral ulcers, sore throat, pain in legs, hands and
feet, dizziness, tachycardia, nausea, diarrhoea, depres-
sion, fatigue, chills, burning sensations in the face, cold
hands, increased blood pressure and submandibular
lymphadenopathy. The increase in complaints was
transient and disappeared within a week or two.
Discussion
The aim of this study was to investigate long-term
changes in subjective health complaints after the
removal of all amalgam fillings in a group of patients
who attributed health complaints to amalgam fillings.
The main finding was that the long-lasting reductions
Table 4. Repeated measures analysis of changes in health complaints over time. Per-protocol (PP) and intention-to-treat (ITT) repeated
measures analysis of changes in health complaints in the treatment group and the reference group. Mean index scores, standard











P-value*Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.)
Treatment group
Intra-oral index (PP) 18 8Æ6 (6Æ9) 6Æ6 (3Æ8) 6Æ7 (4Æ5) 4Æ7 (5Æ2) 5Æ2 (3Æ8) 0Æ026
Intra-oral index (ITT) 20 8Æ4 (6Æ6) 6Æ8 (3Æ7) 6Æ4 (4Æ5) 4Æ8 (5Æ0) 4Æ9 (3Æ8) 0Æ015
Extra-oral index (PP) 18 6Æ7 (8Æ8) 6Æ7 (7Æ1) 5Æ7 (6Æ4) 2Æ4 (3Æ2) 4Æ8 (4Æ3) 0Æ004§
Extra-oral index (ITT) 20 6Æ9 (8Æ4) 6Æ8 (6Æ8) 5Æ6 (6Æ3) 2Æ8 (3Æ8) 4Æ9 (4Æ4) 0Æ009§
General index (PP) 18 41Æ4 (16Æ4) 42Æ9 (21Æ3) 39Æ0 (24Æ3) 32Æ1 (19Æ2) 31Æ6 (14Æ5) 0Æ001
General index (ITT) 20 41Æ5 (16Æ0) 42Æ7 (20Æ4) 37Æ9 (23Æ2) 31Æ6 (18Æ5) 31Æ4 (13Æ9) <0Æ001
Reference group
Intra-oral index (PP) 12 11Æ0 (12Æ0) n.a. n.a. 10Æ8 (12Æ8) 15Æ4 (13Æ4) 0Æ245§
Intra-oral index (ITT) 20 13Æ0 (12Æ0) n.a. n.a. 11Æ3 (12Æ4) 13Æ6 (12Æ2) 0Æ246§
Extra-oral index (PP) 12 10Æ8 (10Æ6) n.a. n.a. 9Æ4 (11Æ4) 12Æ5 (12Æ6) 0Æ179§
Extra-oral index (ITT) 20 11Æ0 (9Æ3) n.a. n.a. 10Æ0 (10Æ0) 11Æ6 (10Æ8) 0Æ259§
General index (PP) 12 43Æ1 (18Æ1) n.a. n.a. 38Æ3 (23Æ3) 49Æ5 (28Æ5) 0Æ004§
General index (ITT) 20 47Æ3 (21Æ2) n.a. n.a. 41Æ3 (25Æ2) 49Æ6 (27Æ3) 0Æ004§
n.a., not applicable.
*P-value from analysis of variance for repeated measures.
†For the reference group, mean index scores from Questionnaire 2 were used.
‡For the reference group, mean index scores from Questionnaire 3 were used.
§Wilks’ Lambda.
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in intra-oral and general health complaints in the
treatment group were significantly different from the
change in the reference group, in which there were no
long-lasting reductions.
In the treatment group, intra-oral and general health
complaints were significantly reduced 3 years after
completed replacement of amalgam fillings. Reductions
in subjective health complaints after replacement of
amalgam fillings have also been found in previous
studies (24, 25). The reference group received no
intervention, and no improvement in health com-
plaints was found. This is in agreement with data from
patients with health complaints attributed to dental
restorations, mainly dental amalgam, who did not
change the restorations to other materials (8).
It is necessary to consider several factors that may
have influenced the results. First, there has been a
reduced exposure to mercury in the treatment group.
Previous studies have established that people with
amalgam fillings have higher concentrations of mercury
in blood, plasma, urine and body organs than people
without amalgam fillings (12, 15, 17–19, 31). The
finding of reduced levels of mercury in serum and urine
in the present study is in agreement with data from
several studies showing that replacement of amalgam
fillings leads to reduced levels of mercury in blood,
plasma and urine (14, 32, 33). Despite this, studies
investigating the relationship between amalgam fillings
and reported health complaints have not found positive
correlations between number of amalgam fillings and
Treatment group 


























































































































































Fig. 3. Individual index scores from
3-year follow-up and Questionnaire
3 plotted against scores from Ques-
tionnaire 1. Index scores for intra-
oral, extra-oral and general health
complaints from treatment group
(left column) at 3-year follow-up
plotted against index scores before
amalgam removal (Questionnaire 1).
For the reference group (right col-
umn), index scores from Question-
naire 3 were plotted against index
scores from Questionnaire 1. Data
from intention-to-treat analyses (last
value carried forward) are marked
with grey dots in the diagrams.
Results from statistical analyses of
data are given in Table 3.
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number of reported complaints (9, 18), indicating that if
there is a causal relationship between amalgam fillings
and health effects, there is not a simple dose–response
relationship between exposure to amalgam fillings and
reported health complaints. In a recently published
study on health effects after removal of amalgam fillings
(34), correlations between amalgam-filled surfaces and
symptom scores were not statistically significant. How-
ever, positive moderate correlations were found
between mercury levels in both plasma and urine and
subjective health complaints, and between reductions in
mercury levels in these media and reductions in
subjective health complaints (34). In the present study,
we found positive but not significant correlations
between reduction in mercury concentration in serum
and reductions in subjective health complaints, which
may be in agreement with the analyses presented in
(34). It is possible that some individuals are highly
sensitive to mercury from dental amalgam and may
benefit from reduced exposure (35).
The reference group received no treatment and was
only followed up by questionnaires sent by post. This
makes it difficult to untangle the effects of the general
care associated with amalgam replacement and follow-
ups in the treatment group from the effects of the
amalgam replacement itself. Follow-ups in the treat-
ment group were carried out by health personnel with
both time and motivation to listen to and understand
the patients’ experiences. This may have contributed to
the reduction in reported subjective health complaints
as patient-centred communication has been shown to
be associated with improved patient health outcomes
(36, 37). In addition, participants in the treatment
group no longer had to worry about possible adverse
effects from their amalgam fillings. This may also have
played a part in the reduction in health complaints as
worry has been found to lead to increased monitoring
of complaints, which again may lead to an increased
feeling of ill health (38). Even so, replacement of
amalgam fillings will usually take place in a treatment
context where factors like these are present and, thus,
potentially might influence the treatment results. Par-
ticipants’ belief in amalgam replacement as an effective
treatment (39) and gratitude in relation to having the
replacement covered by project funds could possibly
have resulted in a response bias towards reporting
reduced health complaints. However, it is not likely
that the participants would remember how they
responded to the scales in the questionnaires several
years ago. Factors mentioned above are linked to
components related to placebo (expectations, condi-
tioning, learning, memory, motivation, somatic focus,
reward, anxiety reduction and meaning), as defined as
a genuine psychobiological event attributable to the
overall therapeutic context (40). In this context, it is
also possible that for some patients, the presence of
amalgam fillings has been associated with a nocebo
effect. Removal of amalgam fillings could therefore
result in a discontinuation of this effect and conse-
quently lead to a reduction in reported health com-
plaints.
Reduction in intra-oral health complaints may have
been influenced by general effects of the dental treat-
ment received during the amalgam replacement pro-
cess. It does, however, seem unlikely that an effect of
a generally improved dental health should be promi-
nent 3 years after completed replacement, given that
patients with need for complicated dental rehabilitation
were excluded from the treatment group and that the
removed amalgam fillings were described as sound and
well-functioning.
Participants included in this study were recruited
from patients referred to the Dental Biomaterials
Adverse Reaction Unit. Consequently, participants are
not representative of all patients with health complaints
attributed to amalgam fillings. Not all patients with
























Urine (nmol per mmol crea)
Fig. 4. Mean mercury concentration in serum and urine at pre-
treatment examination and at follow-up after removal of amalgam
fillings. Mean mercury concentration (and s.d.) in serum (nmol
L)1) and urine (nmol per mmol creatinine) at pre-treatment
examination and at follow-up after removal of amalgam fillings.
Mercury concentration in both serum and urine was significantly
reduced after amalgam removal (P < 0Æ001, and P = 0Æ004, respec-
tively).
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referred to this unit. Some patients are directly treated
by their own dentist or general practitioner or seek help
from practitioners of alternative medicine. Despite lack
of objective signs of adverse reactions to dental amal-
gam, some patients nevertheless have all their amalgam
fillings removed of their own accord because they are
concerned about possible adverse effects of mercury
released from amalgam fillings. The participants
included in this study had not removed all amalgam
fillings, either because they accepted that there were no
indications for amalgam removal or because they did
not have the financial means necessary for amalgam
removal. Thus, the treatment group is not directly
comparable with patients who remove amalgam resto-
rations of their own accord (23).
The study was designed as a before-and-after study
with a comparison group (reference group). Compari-
sons between the reference group and the treatment
group must be interpreted with caution. Even though
power calculations showed acceptable power of the
study, the sample size is small and the results should be
considered in context with results from comparable
studies (8, 24, 25, 41). A larger sample size could
provide more precise estimates and less-wide confi-
dence intervals. In addition, there may be unknown
factors that influence reporting of health complaints
over time in the groups. Another limitation could be
that as the outcome is based on the participants’
reporting of health complaints, the study is open for
response bias in both the treatment group and the
reference group.
In the treatment group, all 20 participants completed
replacement of amalgam fillings, and 19 of the partic-
ipants were able to attend the 3-year follow-up. In the
reference group, seven of the 20 participants were lost
to follow-up or excluded because of completed removal
of amalgam fillings (Fig. 1). The response rate in the
reference group was influenced by the fact that only
two reminders, by letter, is allowed by the Regional
Committee for Medical Research Ethics. This is in line
with the standards used by the Norwegian National
Committee for Medical and Health Research Ethics. As
there were no major differences between the results
from the per-protocol analyses and the intention-to-
treat analyses, we assume the potential bias from
non-random dropout of participants or exclusion of
‘protocol violators’ (participants in the reference group
who removed amalgam during the study) had no major
impact on the result.
Exclusion criteria were initially not applied in the
reference group. The clinical examination necessary to
fully apply these criteria could potentially lead to a
renewed focus on amalgam fillings as a possible cause of
ill health, thus increasing the risk of participants in the
reference group initiating amalgam removal of their
own accord. As no intervention was planned for the
reference group, the participants were not asked to
undergo a clinical examination. The patients excluded
from the treatment group were, based on their
responses to Questionnaire 1, quite similar to the
treatment group and the reference group, with the
exception of per cent on sick leave or disability pension.
For this variable, exclusion of the 10 patients resulted in
a more equal occupational status for the treatment
group and the reference group (Table 2). Changes in
health complaints in the treatment group were com-
pared with changes in both the initial reference group
and changes in the reference group after post hoc
application of exclusion criteria. No major differences
were found between the two comparisons. However, as
there was no clinical pre-treatment examination of
patients in the reference group, there could still be
differences between the groups. The bias from differ-
ences between the groups at study start is expected to
be limited.
Treatment of patients with subjective health com-
plaints attributed to amalgam fillings should only be
considered after a thorough medical and dental exam-
ination has been carried out and other causes for the
complaints have been eliminated or adequately treated
(42). The results from the present study, and other
studies investigating the effects of amalgam replace-
ment, indicate that replacement of amalgam fillings is
associated with reductions in subjective health com-
plaints at group level. The mechanisms behind this are
not known, and other treatment options than amalgam
replacement should also be considered. In a recent
randomised clinical trial, all investigated treatments
(amalgam removal, amalgam removal plus biological
detoxification and health promotion without amalgam
removal) resulted in clinically relevant reductions in
health complaints (25). When considering replacement
of intact amalgam fillings, potential benefits must be
balanced with risks associated with the dental treatment
(e.g. tooth fractures or endodontic complications).
When removing amalgam fillings, measures should be
taken in order to minimise exposure to mercury for both
patients and dental personnel (29, 42).
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The results from the present study indicate that the
replacement of amalgam fillings was associated with
reductions in subjective health complaints at group
level. The mechanisms behind this remain to be
identified. Reduced exposure to mercury, patient-cen-
tred treatment and follow-ups, and elimination of
worry are factors that may have influenced the results.
In this study, we investigated changes in index scores.
More knowledge is needed about changes in specific
complaints included in the index scores after replace-
ment of amalgam fillings, and a characterisation of the
treatment group in this respect is warranted.
Acknowledgments
Associate professor Olav Bøe, Department of Clinical
Dentistry, Faculty of Medicine and Dentistry, Univer-
sity of Bergen, is acknowledged for constructive partic-
ipation in discussions on statistical issues. Siren
Hammer Østvold is acknowledged for technical assis-
tance in relation to sample collection. The project was
funded by the Norwegian Ministry of Health and
supported by the Centre for Clinical Dental Research
at the Faculty of Medicine and Dentistry, University of
Bergen, Norway.
References
1. Powers J, Sakaguchi R. Amalgam. In: Powers J, Sakaguchi R,
eds. Craig’s restorative dental materials, 12th edn. St. Louis:
Mosby Elsevier; 2006:235–267.
2. Malt UF, Nerdrum P, Oppedal B, Gundersen R, Holte M,
Lone J. Physical and mental problems attributed to dental
amalgam fillings: a descriptive study of 99 self-referred
patients compared with 272 controls. Psychosom Med.
1997;59:32–41.
3. DeRouen TA, Martin MD, Leroux BG, Townes BD, Woods JS,
Leitao J et al. Neurobehavioral effects of dental amalgam in
children: a randomized clinical trial. JAMA. 2006;295:1784–
1792.
4. Bellinger DC, Trachtenberg F, Barregard L, Tavares M,
Cernichiari E, Daniel D et al. Neuropsychological and renal
effects of dental amalgam in children: a randomized clinical
trial. JAMA. 2006;295:1775–1783.
5. SCENIHR. Scientific opinion on the safety of dental amalgam
and alternative dental restoration materials for patients and
users (6 May 2008). Available at: http://ec.europa.eu/health/
ph_risk/committees/04_scenihr/docs/scenihr_o_016.pdf, accessed
15 February 2011.
6. US Food and Drug Administration. Dental devices: classifica-
tion of dental amalgam, reclassification of dental mercury,
designation of special controls for dental amalgam, mercury,
and amalgam alloy; final rule. Fed Regist. 2009;74:38685–
38714.
7. Bellinger DC, Daniel D, Trachtenberg F, Tavares M, McKinlay
S. Dental amalgam restorations and children’s neuropsycho-
logical function: the New England Children’s Amalgam Trial.
Environ Health Perspect. 2007;115:440–446.
8. Lygre GB, Gjerdet NR, Björkman L. A follow-up study of
patients with subjective symptoms related to dental materials.
Community Dent Oral Epidemiol. 2005;33:227–234.
9. Ahlqwist M, Bengtsson C, Furunes B, Hollender L, Lapidus L.
Number of amalgam tooth fillings in relation to subjectively
experienced symptoms in a study of Swedish women. Com-
munity Dent Oral Epidemiol. 1988;16:227–231.
10. Björkman L, Pedersen NL, Lichtenstein P. Physical and mental
health related to dental amalgam fillings in Swedish twins.
Community Dent Oral Epidemiol. 1996;24:260–267.
11. Bates MN, Fawcett J, Garrett N, Cutress T, Kjellstrom T.
Health effects of dental amalgam exposure: a retrospective
cohort study. Int J Epidemiol. 2004;33:894–902.
12. Olstad ML, Holland RI, Wandel N, Pettersen AH. Correlation
between amalgam restorations and mercury concentrations in
urine. J Dent Res. 1987;66:1179–1182.
13. Berglund A. Estimation by a 24-hour study of the daily dose of
intra-oral mercury vapor inhaled after release from dental
amalgam. J Dent Res. 1990;69:1646–1651.
14. Molin M, Bergman B, Marklund SL, Schutz A, Skerfving S.
Mercury, selenium, and glutathione peroxidase before and
after amalgam removal in man. Acta Odontol Scand.
1990;48:189–202.
15. International Programme on Chemical Safety. Environmental
health criteria 118. Inorganic mercury. Geneva: World Health
Organization; 1991.
16. Björkman L, Lind B. Factors influencing mercury evaporation
rate from dental amalgam fillings. Scand J Dent Res.
1992;100:354–360.
17. Lygre GB, Grønningsæter AG, Gjerdet NR. Kvikksølv og
amalgamfyllinger [Mercury and dental amalgam fillings].
Tidsskr Nor Laegeforen. 1998;118:1698–1701.
18. Langworth S, Björkman L, Elinder CG, Järup L, Savlin P.
Multidisciplinary examination of patients with illness attrib-
uted to dental fillings. J Oral Rehabil. 2002;29:705–713.
19. Björkman L, Lundekvam BF, Lægreid T, Bertelsen BI, Morild
I, Lilleng P et al. Mercury in human brain, blood, muscle and
toenails in relation to exposure: an autopsy study. Environ
Health. 2007;6:30.
20. Needleman HL. Mercury in dental amalgam – a neurotoxic
risk? JAMA. 2006;295:1835–1836.
21. Issa Y, Brunton PA, Glenny AM, Duxbury AJ. Healing of oral
lichenoid lesions after replacing amalgam restorations: a
systematic review. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 2004;98:553–565.
22. Vamnes JS, Lygre GB, Grønningsæter AG, Gjerdet NR. Four
years of clinical experience with an adverse reaction unit for
dental biomaterials. Community Dent Oral Epidemiol.
2004;32:150–157.
23. Lygre GB, Gjerdet NR, Björkman L. Patients’ choice of dental
treatment following examination at a specialty unit for
H E A L T H COMP L A I N T S A F T E R R EMOVA L O F D EN T A L AMA LGAM 847
ª 2011 Blackwell Publishing Ltd
adverse reactions to dental materials. Acta Odontol Scand.
2004;62:258–263.
24. Nerdrum P, Malt UF, Hoglend P, Oppedal B, Gundersen R,
Holte M et al. A 7-year prospective quasi-experimental study
of the effects of removing dental amalgam in 76 self-referred
patients compared with 146 controls. J Psychosom Res.
2004;57:103–111. (comment in: J Psychosom Res. 2005;59:
189–190; author reply 191–192).
25. Melchart D, Vogt S, Kohler W, Streng A, Weidenhammer W,
Kremers L et al. Treatment of health complaints attributed to
amalgam. J Dent Res. 2008;87:349–353.
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Abstract
In this article, we explore how patients with health complaints attributed to dental amalgam experienced and gave meaning
to changes in health complaints before, during, and after removal of all amalgam fillings. We conducted semistructured
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conducted an explorative and reflective thematic analysis and identified the following themes: Something is not working:
betrayed by the body, You are out there on your own, Not being sure of the importance of amalgam removal, The relief
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Themeanings given to symptoms anddistress can
transform suffering. Meaning*any meaning*
serves to turn back the tide of chaos and
bafflement that confronts us in affliction. Given
specific meaning, illness becomes metaphor*a
rhetorical resource to be used to explore and
communicate the wider significance of our
predicament. (Kirmayer, 1994, p. 183)
Patients suffering from health complaints which
cannot be fully explained by the doctors’ findings
might find it difficult to assign meaning to their
illness experiences (Kornelsen, Atkins, Brownell, &
Woollard, 2015; Madden & Sim, 2006). How can
they understand the experienced pain and discom-
fort when the biomedical ‘‘stamp of approval’’*a
diagnosis*is apparently not within reach? How can
they justify not being able to partake in activities as
they did previously when their suffering remains
unconfirmed by the medical system?
It is well known that mercury vapor released from
amalgam fillings can be inhaled and absorbed into the
bloodstream (Clarkson, Magos, & Myers, 2003).
Some patients fear their health complaints might be
caused or aggravated by mercury released from their
amalgam fillings (Sjursen et al., 2014; Tillberg et al.,
2005). Patients who attribute health complaints to
their dental amalgam fillings are a heterogeneous
group. Common to all of them is that they suffer from
unexplained or partially explained health complaints
that they believe are caused or aggravated by their
amalgam fillings. For some, only one or a few local
complaints such as taste disturbances, dry mouth,
and intraoral pain are attributed to the dental
amalgam. The majority describe a number of both
local and general health complaints involving several
organ systems. Tiredness, headaches, pain in muscles
and joints, and problems with memory and concen-
tration are among the most frequently reported
complaints (Langworth, Björkman, Elinder, Järup,
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& Savlin, 2002; Lygre, Gjerdet, & Björkman, 2005;
Vamnes, Lygre, Grönningsæter, & Gjerdet, 2004).
For some patients, contact allergic reactions might be
present, and removal of amalgam fillings in contact
with such lesions is generally recommended (Issa,
Brunton, Glenny, & Duxbury, 2004; Lygre, Gjerdet,
& Björkman, 2004). For the majority of patients with
health complaints attributed to dental amalgam, no
objective signs of adverse reactions can be observed
(Langworth et al., 2002; Vamnes et al., 2004). Never-
theless, one cannot preclude the possibility that
dental amalgam could have deleterious effects on
the health of highly susceptible people (Needleman,
2006; US Food and Drug Administration, 2009).
This poses the following dilemma: Even though there
is not sufficient evidence to lend scientific credibility
to an amalgam syndrome diagnosis, standard safety
margins are lacking, thus making it impossible to rule
out that, for some people, amalgam might be associ-
ated with a risk of negative health effects (Richardson
et al., 2011).
Studies investigating changes in general health
complaints after removal of amalgam fillings have
found reductions in health complaints (Lygre et al.,
2005; Melchart et al., 2008; Nerdrum et al., 2004;
Sjursen et al., 2011), but not to the levels found in the
general population (Lygre et al., 2005; Nerdrum
et al., 2004). The observed reductions in health com-
plaints might be interpreted as effects of patients
being seen andheard, improved dental conditions, the
natural variation in the course of the complaints,
reduced exposure tomercury, as well as placebo effect
and discontinued nocebo effect (Melchart et al.,
2008; Nerdrum et al., 2004; Sjursen et al., 2011).
Because of difficulties in masking whether patients
have their amalgam fillings removed or not, ran-
domized clinical trials of the effects of amalgam
removal are likely to be influenced by participants’
expectations.
In previous studies, patients’ experiences have
seldom been explored on their own terms. In a focus
group study from New Zealand (Jones, 2004) with
35 participants having amalgam-related complaints,
participants described experiencing psychological
problems such as memory loss and mood swings
that they believed were related to their amalgam
fillings. They also described experiencing psycholo-
gical problems, such as loss of social support and
considering suicide, that they related to suffering
from symptoms that were not easily diagnosed and
thereby often treated as indicating hypochondriac
tendencies. Of the participants who had removed all
amalgam fillings, the majority reported improved
health; some even to the extent of full recovery (Jones,
2004). In a Swedish interview study (Stahlnacke &
Soderfeldt, 2013) of persons who attribute health
problems to dental filling materials, mostly dental
amalgam, the participants described a variety of long-
lasting health problems that they believed were
caused by dental amalgam. Replacement of dental
materials was the main treatment for these prob-
lems, and the majority of the participants reported
having had good experiences with health professio-
nals, although some negative encounters were also
reported (Stahlnacke & Soderfeldt, 2013).
When patients suffer from health complaints that
cannot be easily explained, both patients and health
personnel find themselves in a situation where the
normal expectations of the medical encounter cannot
be met. To be better able to meet the patient where he
or she is, it is important that health personnel take the
time to learn more about how patients interpret and
give meaning to their health complaints. Patients
experience and give meaning to health complaints in
their everyday life, and it is therefore important to
know how the patients’ thoughts, obligations, past
experiences, and perceptions of the future interact
with the perceived pain and discomfort. Conse-
quently, for patientswith health complaints attributed
to dental amalgam, it is not only necessary to bridge
the gap between the medical and dental aspects, it is
also necessary to bridge the gap between how the
complaints are understood in the physician’s/dentist’s
office and how they are understood and experienced
in the context of the patient’s everyday life.
In a previous article (Sjursen et al., 2014), we
explored how patients came to attribute their un-
explained health complaints to dental amalgam. In
this article, our aim is to explore how the same
patients experienced and gave meaning to changes in




Participants were recruited from the intervention
group in aNorwegian amalgam removal trial (Sjursen
et al., 2011). To be eligible for participation in the
intervention group of the trial, participants had to
fulfill the following criteria: initially referred to a
specialty unit for examination of health complaints
attributed to dental amalgam; no signs of contact
allergic reactions to dental amalgam and thereby not
recommended for removal of amalgam fillings; amal-
gam fillings still present; health complaints from
at least three organ systems; mercury level data avail-
able from initial examination; no allergy to resin-
based dental materials; no need for complicated
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dental therapy; and no severe medical disorders/food
allergies/psychological difficulties.
The 20 participants in the intervention group had
all their amalgam fillings replaced with other restora-
tive materials by their regular dentists. Amalgam
fillings were removed according to guidelines ensur-
ing minimal exposure from mercury (Dental Bioma-
terials Adverse Reaction Unit, 2002). The cost of the
amalgam removalwas covered by project funds for the
amalgam removal trial. Follow-ups took place ap-
proximately 3 months and 1, 3, and 5 years after the
participants had completed the removal of all their
amalgam fillings. At the 5-year follow-up, 12 (seven
women and five men) of the participants were invited
to participate in qualitative research interviews. All
accepted, and interviews were scheduled accordingly.
At the time of the interviews, age range of the parti-
cipantswas from45 to 65 years (mean age 54.4 years).
After the completion of the 12 interviews, we were
able to identify both convergent and divergent experi-
ences in our data material. As we did not have the
impression that the last interviews brought to light
new themes, we decided to stop recruiting partici-
pants at this point.
Sampling method
We used a purposive sampling procedure to recruit
participants from the intervention group in an amal-
gam removal trial to explore how they experienced
and gave meaning to changes in health complaints
before, during, and after amalgam removal. By choos-
ing this sampling procedure, we were able to obtain a
homogenous sample with regard to all participants
having had their amalgam fillings removed. When it
came to the demographic characteristics, participants
were selected to ensure that a diverse age range and
both sexes were represented.
Researchers
The interview study was carried out as a cross-
disciplinary collaboration between three psycholo-
gists, two dentists, and one operating nurse. Together
we have varied clinical experience, as well as a diverse
experience with both qualitative and quantitative
research methods.
Data collection
To lay the basis for an open exploration of partici-
pants’ experiences of changes in health complaints
and how they assigned meaning to these, we chose to
carry out semistructured, exploratory, in-depth inter-
views. The first author, in close cooperation with the
fifth author, carried out all interviews. Neither had
been present at the follow-ups, and the interviews
were held at a different location than the follow-ups.
After each interview, the first and fifth author adjusted
the interview guide that had been initially developed
by all the authors. The interviews were videotaped.
Mean duration of the interviews was 60 min (range
32 min to 2 h 9 min).
Analysis
By reading and comparing the individual accounts,
we wanted to identify similarities and discrepancies
in the ways in which the participants experienced and
gave meaning to changes in health complaints before,
during, and after amalgam removal.We conducted an
explorative and reflexive thematic analysis (Binder,
Holgersen, & Moltu, 2012; Braun & Clarke, 2006),
which can be summarized as follows: (a) the first
author transcribed all interview recordings verbatim,
(b) to get a basic sense of patterns in the partici-
pants’ experiences, all authors read through the writ-
ten material separately, (c) to establish meaningful
themes, each author discussed the material with the
first author, (d) the first author organized the text
material, with the assistance of the NVivo9 software
(QSR International Pty Ltd., 2010), into ‘‘nodes’’ in
accordance with these themes, (e) in cooperation with
the coauthors, the themes were additionally refined
and condensed into the presented findings, and (f)
examples and quotes were selected to illustrate how
patients experienced and gave meaning to changes in
health complaints. To strengthen the transparency of
the analysis, we presented thick descriptions and used
quotes that exemplify the themes (Denzin, 2001;
Geertz, 1973; Ponterotto, 2006).
Ethical concerns
Participants received written and verbal information
about the interviews at the time of the 5-year follow-
up, and all included participants signed a consent
form. Before they entered the interview room, the
participants were reminded that the interviews were
going to be videotaped. The Regional Committee for
Medical and Health Research Ethics in Western
Norway, and the Norwegian Social Science Data
Services approved the study. To safeguard the
anonymity of participants, findings are presented
without identifying details.
Findings
In our analyses of how patients experienced and gave
meaning to changes in health complaints before,
Patients’ experiences of changes
Citation: Int J Qualitative Stud Health Well-being 2015, 10: 28157 - http://dx.doi.org/10.3402/qhw.v10.28157 3
(page number not for citation purpose)
during, and after amalgam removal, we found the
following themes to be of importance:
a. Something is not working: betrayed by the
body.
b. You are out there on your own.
c. Not being sure of the importance of amalgam
removal.
d. The relief experienced after amalgam removal.
e. To accept, to give up, or to continue the
search.
Something is not working: betrayed by the body. The
starting point for all participantswas the experience of
something not working inside their bodies. Some
had struggled with health complaints from an early
age, whereas others experienced onset of complaints
as adults. The majority of the participants described
the onset of complaints as gradual, but some pin-
pointed more distinct starting points for the health
complaints they attributed to dental amalgam. Sev-
eral of the participants already had*or went on to
receive*other diagnoses explaining part of their
complaints; nevertheless, they felt that something
remained unexplained. Participants’ complaints dif-
fered in kind, number, and intensity. The following
complaints were mentioned most often: pain in
muscles and joints, headaches, memory problems,
tiredness, gastrointestinal symptoms, and intraoral
health complaints. For some, the discomfort and
impairment were limited to a few distinct complaints;
for others, it was the sum of the complaints*more
than the separate complaints in themselves*that
posed the main burden. Some participants were
puzzled by the way the complaints made them feel
‘‘beside themselves’’ or ‘‘out of it.’’
I was in so much pain, and I also felt, for a
while, that I had such a poor memory (sighs).
I cannot say if that was because of stress caused
by having to fight the pain, but I did feel ‘‘out
of it’’ in a way. I really did.
Some described their bodies as being overly sensi-
tive to many different things to a degree that some
even felt betrayed by their bodies. They found it
necessary to avoid certain foodstuffs, such as wheat
and/or sugar, and some also developed respiratory
reactions and headaches from certain odors such as
perfume and paint.One participant described some of
her puzzling complaints and asked, ‘‘What causes it?
Why did it happen? Was it because of my strange
body? Who knows?’’ Another participant seemed
saddened that her body was not working as well as
others’ appeared to function. Because of her com-
plaints, she was only able to keep a part-time job, and
even then, she often felt exhausted and in pain after
work. Several described how the health complaints
had negative consequences for their social life. They
recounted the various ways the complaints and, in
particular, the depleted energy levels and nausea
caused by the pain limited their ability to keep up
with family life and professional obligations. They felt
they could not perform as well, or at least not as
effortlessly, as others seemed to be able to do. Despite
having families that gave them support and under-
standing, several described a profound feeling of
sadness related to not being able to be the spouse/
parent they wanted to be. Several also felt that their
relationship with friends and colleagues suffered
because of their complaints. They seldom had the
energy to meet people socially, and when in pain, they
had to pull themselves together to avoid responding
more harshly than they wanted to in tense situations.
All participants worked hard to ensure that they did
not lash out and hurt the people around them, and
most of the time they thought they succeeded with
this. This was very important to all of them, and the
occasional slip-up was not taken lightly.
If it only affected oneself, it would be more
than terrible, but it gets even worse if it hurts
others. And sometimes it ends up in a way that
one is not able to be the person one would like
to be.
It became important not only for them but also for
the significant people in their lives, to search for a
way to understand and hopefully cure the com-
plaints.
You are out there on your own. The majority of the
participants in our sample said that they had been
actively trying to find explanation for their com-
plaints. Several were disappointed by how little the
medical profession had to offer when it came to
health complaints in the absence of corresponding
objective findings.
I’m not quite able to sort it out, and the doctors
are not very good at helping with these things
when they do not find anything specific. . .. So in
a way, you have to sort it out on your own.
In addition to seeking help from physicians and
dentists, participants also had consulted physiothera-
pists, chiropractors, and practitioners of alternative
medicine. For some participants, this had yielded
immediate and striking results, such as the case of one
participant, who consulted a healer because of a
locked temporomandibular joint.
T. T. Sjursen et al.
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Then I saw a healer for the first time, and I
have never experienced anything so strange.
I mean, he didn’t even touch me, but it creaked
and groaned and after that, I have been able to
open my mouth wide.
A few of the participants who had consulted
practitioners of alternative medicine had developed
quite close relationships with some of them. In
addition to the treatment per se, it seemed that these
therapists filled an important role as emphatic listen-
ers and givers of advice relating to many aspects of the
participants’ lives. Other participants only sought
treatment when they needed help to manage specific
complaints. They tried to limit the number of treat-
ment sessions as these were described as expensive
and time consuming. There were also participants
who had spent a considerable amount of time, energy,
and money on treatments that were described as
having from minor effect to no effect at all.
Participants had also made other changes in their
lives, hoping to diminish their health complaints.
Several had tried different diets, sometimes through
trial-and-error, and other times on advice given at
rehabilitation centers or by practitioners of alternative
medicine. For most, the results were promising at
first, but the beneficial changes did not last over time.
Several participants, however, did continue to avoid
or limit the intake of certain food types as they
experienced this to be somewhat helpful. Most of
the participants had also modified their work situa-
tion. Some had started working reduced hours, some
had changed to jobs that were less physically taxing,
and some had started saying ‘‘no’’ more often at work.
One participant said that the questions the project’s
physician had asked her at the pretreatment examina-
tion led her to take a closer look at the way she was
living her life, and she had realized that she needed to
make more room for herself in her own life.
Participants varied as to how and when dental
amalgamwas suspected to be a possible cause for their
body not working properly (Sjursen et al., 2014).
When they first contacted the specialty unit, there was
considerable media coverage of possible harmful
effects of dental amalgam, and all participants ac-
knowledged having heard about this possible connec-
tion through the media or through accounts from
friends and acquaintances. In addition, they had all
experienced something that made the link between
dental amalgam and health complaints seem person-
ally relevant. For some, dental amalgam ended up as
the only plausible explanation remaining after they
had tried everything else; for others, dental amalgam
was thought to be only one of many factors influen-
cing their health. Common to all participants was a
strong desire to have the amalgam removed once the
attribution of health complaints to dental amalgam
was made.
Not being sure of the importance of amalgam removal.
Participants said that they were very happy to be
given the opportunity to have all amalgam fillings
removed through participation in the clinical trial.
Several pointed out that they would otherwise not
have been able to afford such extensive dental
treatment. Many of the participants emphasized
that they had felt well taken care of both by their
dentist and by the personnel at the specialty unit
during follow-ups. To limit patients’ exposure to
mercury, a protective sheet (rubber dam) made from
silicone was used during amalgam removal. Several
of the participants said this made them feel well-
protected. A few patients had experienced illness
episodes after treatment sessions. Two of the pa-
tients who had experienced adverse reactions said
that they felt worse after treatment sessions when
the rubber dam had been difficult or impossible to
place.
When responding to the opening question: ‘‘Have
you experienced any changes in health complaints or
quality of life after the amalgam removal?’’ nine
participants said that they had experienced changes
for the better. One participant said she was unable to
answer this question because she had been in a very
demanding life situation at the time of the amalgam
removal. Two men answered no to this question.
They had both received other diagnoses and no
longer suspected that dental amalgam was the cause
of their complaints. The participants who had
experienced changes for the better were somewhat
hesitant when it came to identifying the amalgam
removal as a direct cause for the changes. After they
described the perceived changes in health com-
plaints, they usually tried to sort out which changes
they thought were caused by the amalgam removal
and which were more likely to have been brought on
by other changes in their lives.
Well, what I think is that I don’t really know
what (pause). I think that the amalgam removal
at least has had an effect on my mouth and the
pain I had there. But I (pause) when it comes
to the other complaints, I think that it is kind of
impossible to know if it is [the amalgam
removal] that has made me better or if it is
other things. I have tried a lot of different
things. I have had different treatments, and I
have changed my diet, you know, and I have
started to take Omega-3 supplements, which is
also supposed to be good for the joints, for
instance. So, I really have done other things as
Patients’ experiences of changes
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well, and I really can’t say if it is the teeth or if it
is the other things or if it is (pause). I find this
to be very difficult.
Participants thought that the new white fillings
were much nicer looking than the old black fillings,
and some of the participants said that they felt their
oral condition had greatly improved after the amal-
gam removal. Two participants reported that a taste
disturbance (metallic taste) had disappeared and
they were reasonably certain that this was because
the amalgam had been removed. One participant
had to replace several of the new fillings due to new
caries lesions. Participants found it easier to connect
reduced intraoral health complaints, such as reduced
pain and smarting in the gingiva, to the amalgam
removal, than to connect the more general health
complaints to the removal.
When it came to the general health complaints, all
participants were quick to point out that both the
initial complaints and the subsequent changes might
have been influenced by changes in life situation, work
conditions, and so forth. Several of the participants
used phrases like ‘‘but, of course, this could also have
been influenced by the stress caused by. . ..’’ They also
emphasized that they had been trying several treat-
ment options both before and after the amalgam
removal, and several of the women pointed to
menopause as a possible explanation for reductions
of some health complaints. Some of the participants
had previously taken care of elderly parents, whereas
other participants had this responsibility at the time of
the interview. Some had gone through a divorce or a
painful breakup after the amalgam removal and said
that this had also influenced their health and general
well-being. At the time of the interview, several
participants were in demanding life situations that
negatively affected their health, and several described
how fluctuations of other medical conditions, both
previously known and recently diagnosed, made it
difficult to assess which changes were directly related
to the amalgam removal.
The relief experienced after amalgam removal. Despite
the uncertainties described in the last theme, the
majority of the participants concluded that they were
in a much better place in their lives at the time of the
interview than they had been before the amalgam
removal. With the exception of the two men who
said they had experienced no changes in health
complaints after amalgam removal, all participants
believed that the amalgam removal was partially
responsible for their feeling better.
This amalgam removal, I do believe it has had an
effect, together with all the other things. But I
would have to have psychic abilities to know
exactly how. As I have told you, there are still
periods in which I feel quite poorly and beside
myself, but I do feelmuch better now. I really do.
All participants, including the participant who had
experienced several new caries lesions after the
removal, seemed relieved that they no longer had
any amalgam fillings in their teeth. For many of the
participants, this relief appeared to be associated with
being able to cross a worry off a list.
Participant (P): Well, I was very relieved that I
could have them removed. . .. Because, at that
time, I was very focused on what was causing
me to be not as healthy as others, and this was
something I wanted to try to (pause) that it
might help me get better. So it was certainly a
plus to get rid of it. At least I did not have those
anymore, and I had kind of excluded some-
thing (laughs). It was a little bit like that.
Interviewer (I): Yes, it felt good to
P: You know, some (pause). There are many
people with the same complaints that I have
had who are talking about amalgam and such.
So it is possible that if I still had those fillings
left, I could have been constantly thinking
‘‘Yes, it really could be those fillings keeping
me from feeling well.’’ But it is not like that
anymore, is it?
For almost all participants, there was a distinct
change in emotionality and tone when asked how they
would have felt if they still had one amalgam filling
left. All responded that they would have had it re-
moved and emphasized that they would not have
been happy at all. This stood in stark contrast to the
calm replies of some who had stated that they had
never been totally sure of the connection between
amalgam and health complaints to begin with, and
who conveyed in other parts of the interview a quite
sophisticated understanding of health as being multi-
factorially determined. This uncertainty related to
the importance of the amalgam removal stood almost
paradoxically in contrast to the absolute certainty,
even 5 years after removal, that it was important to
get rid of all amalgam fillings.
To accept, to give up, or to continue the search. Despite
feeling better, as reported by the majority of the
participants, none of them had become symptom-free
after the amalgam removal. They reacted to this in
different ways. For some, there seemed to be a change
in the urgency to seek answers. A few even thought
that they were moving toward accepting their health
T. T. Sjursen et al.
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complaints, or at least toward accepting that their
complaints could never be fully explained.
Well, in a way I have accepted that I will always
have some complaints. I am not like I used to
be when I thought that if only I could find the
right solution, then I would also get cured. I
have kind of given up on that. It is more about
finding the best possible way to live with [the
complaints].
For some participants, this was associated with
growing older and accepting complaints as some-
thing to be expected with advancing age. For others,
the acceptance seemed to be more a consequence of
the limited success of previous attempts at finding
answers. The quest for an answer comes at a cost, as
reflected in the theme, ‘‘You are out there on your
own.’’ In addition to the time and energy spent, there
is also an emotional toll entailed in getting your
hopes up and then being disappointed repeatedly.
The process toward acceptance was described as
containing both elements of relief, in that they could
ease up on the search for an answer, and sadness at
having to let go of their hope for a cure. One
participant who suffered from daily pain and perso-
nal limitations caused by a diagnosed disease very
firmly stated that she preferred a growth perspective
to a pain-coping perspective. She did not want to
dwell on her pain and would much rather participate
in creative-outlet courses instead of pain manage-
ment courses. She had tried both of these and had
experienced that creative and artistic courses en-
hanced her quality of life to a much greater extent
than did pain management courses. For several of
the participants, the search for an answer continued.
Even some of the participants who talked about
accepting their health complaints kept the door open
for other explanations. There were also participants
who regarded the new filling materials with some
skepticism.
And now I just heard that they have started
talking about the new filling materials, the
white ones, you know. Because there are people
who react to those as well, you know.
I have almost nothing like that, because I
mostly have, uhm, porcelain crowns, you know.
That was a conscious choice I made at the
time. However, I have no idea what they used
to cement the crowns.
The not-knowing part of their health complaints
seems to have made acceptance and management of
the complaints difficult. The majority of the partici-
pants had other diagnoses, or went on to receive other
diagnoses, explaining part of their health complaints.
When describing the management of these com-
plaints, including potentially life-threatening adverse
reactions to prescribed medication, participants
seemed less emotionally engaged than when describ-
ing suffering from the complaints they could neither
explain nor knew how to treat.
Discussion
The opening phrase in the interviews was formulated
along the lines: ‘‘The main focus for this interview is
possible changes in health complaints and quality of
life after amalgam removal.However,we do know that
things in life are connected, so we are interested in the
big picture.’’ We thereby opened for a broad under-
standing of what was meant by ‘‘after amalgam
removal’’ because ‘‘after’’ could be understood either
as ‘‘in the period following’’ or as ‘‘caused by.’’ In their
answers, participants seemed to alternate between
these interpretations. When they became aware of
this, they tried to sort out what was reasonable to
connect with the dental amalgam and what might be
related to other things. Most participants stressed
how difficult these were to untangle and how it was
impossible to make strong claims. Through the
participants’ descriptions, a pattern emerged of
‘‘searching for an answer, trying out a solution, and
evaluating the effect.’’ Themajority of the participants
described having been through similar circular pro-
cedures of searching for an answer, trying out a
solution, and evaluating the effect before the amalgam
removal, and some described having started on new
searches after the removal.
When drawing conclusions, one is always at risk of
accentuating some aspects of participants’ experi-
ences over others. In our interview material, the
energy and drive the participants put into their search
for a diagnosis and a cure really stand out. It could be
argued that this automatically follows from the
experienced discomfort; however, the participants
seemed to invest the same drive and energy in taking
care of their families and their work obligations. The
majority of the participants seemed to hold them-
selves to quite high standards and they expressed both
sadness and frustration over not being able simply to
‘‘pull themselves together.’’ Through these descrip-
tions, we were able to glimpse a sense of despair and
chaos; however, this was often quickly brushed aside
with a curt laugh, a joke, or a shift in focus.
According to Cassell (1982, p. 640), ‘‘suffering
occurs when an impending destruction of the person
is perceived; it continues until the threat of integra-
tion has passed or until the integrity of the person
can be restored in some other manner.’’ In more
general terms, Cassel defined suffering as ‘‘the state
of severe distress associated with events that threaten
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the intactness of the person’’ (Cassell, 1982, p. 640).
Consequently, it is not only the pain and the health
complaints in and of themselves that are important,
but also the perceived implications these have for the
individual’s everyday life, hopes for the future, and
sense of self. In our interview material, the ‘‘threat to
the intactness of the person’’ seems mostly to have
been associated with participants’ being unable to
fulfill their obligations as employees and family
members.
Despite this complexity, we find that ‘‘pain’’ and
‘‘suffering’’ are often used interchangeably in every-
day language. This is not a trivial distinction and to
treat it as such can potentially lead to more suffering.
According to Loeser (2000), it is the suffering, and
not the pain, that motivates people to seek medical
care. Nevertheless, it is usually the pain, or the
health complaints, which are addressed by both the
patient and the physician. If patients seek relief for
their suffering, which they perhaps are not even able
to distinguish from their pain, and doctors are
trained to diagnose and treat pain and/or health
complaints, it is hardly surprising that patients with
unexplained health complaints often describe their
encounters with the medical profession as far from
satisfactory.
As argued by Kirmayer (1994, p. 183), suffering
can be transformed by the meanings given to the
experienced symptoms and distress. In continuation
of this, he says that to be effective*that is, ‘‘to carry
private conviction and rhetorical force’’ (p. 184)*the
illness meaning must be perceived as having some
sort of authority. Within a biomedical understanding
of illness and disease, authority is generally granted
through a diagnosis. As summarized by Jutel (2010,
p. 229), a ‘‘medical diagnosis explains, legitimizes,
and normalizes.’’ In the absence of a diagnosis, pa-
tients are denied an explanatory framework through
which they can understand, and potentially give
meaning to, their complaints. It should therefore not
come as a surprise that many patients consider a
diagnosis as a prerequisite for finding meaning and
restoring ‘‘the integrity of the person’’ (Cassell, 1982,
p. 640). For many patients, including our patient
group, a single diagnosis by which all complaints can
be explained cannot always be obtained. This leaves
the patients with more unknowns than answers: Where
are they supposed to direct their energy? Can they
trust that their complaints will staymore or less stable,
or do they have to anticipate getting worse? Should
their efforts be focused on adapting and coping, or
should they continue searching for an explanation and
a cure? How can they integrate their sense of self with
their (new) everyday life?
One thing that seemed to be of importance for
all our participants, with all their similarities and
differences, was the fact that they were all very happy
to have had all their amalgam fillings removed. They
were, however, unwilling to state unequivocally that
they had become better because of the amalgam
removal, and the majority seemed to lean toward the
hypothesis that amalgam removal played a part along
with all the other changes in their lives. Participants
sometimes during the interviews referred to more
simplistic convictions; these were, however, quickly
contrasted with more complex and open-ended
explanations. Different explanations seemed to be
accompanied by different levels of emotions and
rationales. Some of the most important aspects of
the amalgam controversy are perhaps found in the
difference between the rational understanding of
multifactorial explanations of health and the emo-
tional activation seen when a participant imagines
having one amalgam filling left. This underscores
how important it is that both researchers and health
personnel learn more about how patients think, act,
and feel regarding these questions.
Several of the participants in our sample seemed to
construe the amalgam removal as a prerequisite
enabling them to start the process of accepting their
health complaints. Without it, they feared they would
have continued to worry that their amalgam fillings
stood between them and good health. Nevertheless,
our participants were also quick to point out that for
most of their health complaints, they could not be
certain that these were causally linked to their
amalgam fillings. It is reasonable to assume that the
emotional side of the question ‘‘Are my amalgam
fillings making me ill?’’ is often left out of the medical
encounters, or perhaps it is only answered by referring
to statistics and probabilities. Even though health
personnel and researchers might find comfort in, and
take guidance from the evidence indicating that dental
amalgam is a safe treatment option at group level; the
same evidence, with its corresponding statistical and
clinical uncertainties, does not necessarily sound
equally convincing to the patients who are trying to
figure out whether it is true for their lives.
For some patients, it would perhaps be beneficial to
be able to address these issues based not only on
general probabilities but also on the direct conse-
quences the complaints and the uncertainties linked
to the dental amalgamhave in their life. It is our strong
belief that taking the time to address this would be an
important step toward addressing not only the pain
but also the suffering and fear related to the pain. For
some patients, this could result in their being better
able to live with their health complaints and the
uncertainties related to the origin and prognosis of
the complaints. For other patients, the worry deriving
from their dental amalgam could potentially still have
a too negative impact on their quality of life.
T. T. Sjursen et al.
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When considered in light of stories of successful
recoveries in the media, patients’ continued wish to
have their amalgam fillings removed does not appear
unreasonable. Several studies have reported that
patients experience improved health after amalgam
removal (Lygre et al., 2005; Melchart et al., 2008;
Nerdrum et al., 2004; Sjursen et al., 2011). This has
also been described in the qualitative studies per-
formed within this field (Jones, 2004; Stahlnacke &
Soderfeldt, 2013). It has been difficult, however, to
pinpoint the exact causes for the reported health
improvements, and the patients’ health complaints
have not been reduced to such an extent that they
have reached the levels of health complaints found in
the general population.
The fact that we do not fully understand the reason
for the reported improvements is perhaps most
disconcerting for the researchers and the health
professionals. For many patients, a subjective percep-
tion of reduced health complaints will have its own
value irrespective of the mechanisms involved. In
continuation of this, it could be argued that it should
be easier for patients to have all their amalgam fillings
removed. However, removal of dental amalgam
should never be considered a treatment if other
possible causes for the complaints have not yet been
ruled out (Norwegian Directorate of Health, 2008).
In addition, there will always be risks associated with
removing sound dental amalgam fillings. These risks
must be appropriately described by the dentist before
amalgam removal is initiated (Norwegian Directorate
of Health, 2008).
Reflexivity, scope, and limitations
The cross-disciplinary approach of this study enabled
us to look at the patients’ experiences from different
clinical angles; however, there is also a risk that our
clinical stance could overshadow the perspectives of
the patients. At the participants’ first examination at
the specialty unit, no objective findings (i.e., contact
allergic reactions) of adverse reactions to dental
amalgam were found, and it was not recommended
that the participants have their dental amalgam
removed. This also meant that they could not have
the cost of the amalgam removal covered by social
security. In the interviews, the participants expressed
a strongwish to have their fillings removed, but except
for making sure that defective fillings were replaced
with other materials than dental amalgam, no one had
initiated a full amalgam removal on their own. This
could be because they were relatively reassured by the
examination and the advice from the specialty unit, or
it could be because of lack of financial means. From
the interviews, we get the impression that both
explanations played a part. Therefore, we have to
assume that our participantswere not among themost
strongly convinced anti-amalgam patients, and our
findings have to be interpreted accordingly.
When interpreting our findings, it is also important
to take into consideration that the participants had
taken part in a treatment study for which the aim was
to investigate the effects of amalgam removal, and that
they were told in advance that changes in health
complaints after amalgam removal would be the topic
in the interviews. To reduce the impact of links to the
clinical trial, interviews were carried out at a different
location than the follow-ups. Moreover, the inter-
viewer had not been part of the follow-ups. It soon
became clear that the interviewer was nevertheless
considered a member of the specialty unit.
The participants might also have reacted to subtle
cues from the interviewer, perhaps unintentionally
prompting multifactorial explanations at the expense
of other explanations. The fifth author, who listened
in on the interviews, had the impression that
different explanations were met with equal interest.
The participants, however, might have experienced
this differently. It is reasonable to assume that the
topic and context of the interviews might have
accentuated our finding that patients seemed to be
more worried about the health complaints that they
could not explain and which could potentially have
been caused by the dental amalgam, than by pain
and health complaints caused by other diagnosed
medical conditions.
Interviews were performed 5 years after removal of
dental amalgam. The explanations and descriptions
given in the interviewswould have been different if the
interviews had taken place before or shortly after the
amalgam removal. However, the aim of the explora-
tion presented in this article was to learn more about
how participants experienced and gave meaning to
changes in health complaints before, during, and after
amalgam removal, and not to obtain an exact chron-
ological description of every experience. The stories
related by the participants are the stories they live
with, the stories through which they remember and
give meaning to their experiences.
Conclusion
If patients’ experiences 5 years after amalgam removal
can be summarized in a single sentence, the following
might be appropriate: ‘‘The dental amalgam was
certainly important to get rid of, but it is uncertain
how important the removal was for the experienced
changes in health complaints.’’ Patients were very
happy to have had all their amalgam fillings removed,
but they did not believe that they could credit all
the positive changes to the amalgam removal.
Nevertheless, several of the participants said that the
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amalgam removal had been very important because it
meant that they could cross this particular worry off
the list. For some participants, this also meant that
they thought they might be moving toward a personal
acceptance of their health complaints.
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Search strategy for Table 1
The search strategy for identifying prospective studies investigating the effects of 
amalgam removal on general health complaints was based on the following criteria: 
Study group: 
o Patients with general health complaints attributed to dental amalgam 
Prospective study: 
o  Measurements of general health complaints from both before and after 
amalgam removal  
Control group: 
o Changes in health complaints in the amalgam removal group should be 
compared with changes in health complaints in a relevant control group, 
preferably with changes in health complaints in patients with health 
complaints attributed to dental amalgam who did not replace their 
amalgam fillings 
The following search criteria were used to search the PubMed database:  
(amalgam [All Fields]) AND (removal [All Fields]) AND (health [All Fields]) 
AND (follow-up [All Fields] OR longitudinal [All Fields]) NOT (caries [All 
Fields] OR lichenoid [All Fields]) 
The search, which was concluded at May 15, 2016, resulted in 12 hits. Three of these 
references had no comparison group (Begerow, Zander, Freier, & Dunemann, 1994; 
Prochazkova, Sterzl, Kucerova, Bartova, & Stejskal, 2004; Stejskal et al., 1999) one 
was a review (Levey, Carson, & Innes, 2015) and three of the references were papers 
included in the thesis (Paper I, II and IV). Thus, five publications were included in 
Table 1. The paper by Tillberg et al. (2005) was not detected by the PubMed search, 
but was included even though their study group also included participants with health 
complaints attributed to other dental materials. The majority of the participants in the 
study were however initially referred for health complaints attributed to their amalgam 
fillings.
93
Questionnaire regarding current health complaints* 
*translated from Norwegian 
Name: ……………………………………………… 
Address: ……………………………………………. 
Year of birth: …… Month:……...Day:…………….. 
A number of different symptoms are listed on the next pages. Please indicate how you 




0     1     2     3     4     5 6      7     8   9     10 
No complaints         Worst possible complaints 
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0     1     2      3     4     5 6      7     8   9      10 




0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Taste disturbances: I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 




0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints 
Dry mouth: I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 




0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Other complaints:  I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Please describe “other complaints”: ………………………………………………….. 
…………………………………………………………………………………………. 
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0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints 
Facial pain/tenderness: I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 




0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Facial skin problems: I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 





0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints 
Other complaints:  I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Please describe “other complaints”: ………………………………………………….. 
…………………………………………………………………………………………. 
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General complaints associated with: 
Pain from muscles and 
joints:
I-------------------------------------------------------I
0     1     2      3     4     5 6      7     8   9      10 




0     1     2     3     4     5 6      7     8   9      10 




0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
General skin problems: I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints 
Visual disturbances I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 




0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Other complaints:  I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints





0     1     2      3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints 
Dizziness: I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints 
Headaches:
I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Memory problems: I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints 
Difficult to concentrate: I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Anxiety/depression  I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Other complaints:  I-------------------------------------------------------I
0     1     2     3     4     5 6      7     8   9      10 
 No complaints                Worst possible complaints
Please describe “other complaints”: ………………………………………………….. 
…………………………………………………………………………………………. 
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Interview guide – semistructured interview*
*translated from Norwegian 
General briefing at the start of the interview: Mention that things affect one another 
and that changes in one field can result in changes in another. We are interested in 
hearing about changes associated with amalgam replacement, but also about other 
changes during recent years. 
Changes in health complaints 
The main focus of the interview is on any changes that you may have experienced 
(health complaints and life quality) after amalgam replacement.
Have you noticed any change(s)?
Can you tell me something about the complaints you have had? How did they affect 
your daily life? 
Health complaints can have an impact in various ways on how we perceive our body.
Can you tell me something about how your complaints have been affected in terms of: 
Sleep
Appetite
How your body feels – any feeling of tension, restlessness, listlessness? 
How did you first notice a change? 
Tell me specifically what is different on an ordinary day. 
99
How do you experience your early morning/morning/afternoon/evening/night now in 
comparison with before?
Work tasks and relationships with colleagues 
Have the changes affected how you feel at work/in terms of the work tasks you 
normally perform?
If yes: 
Can you describe these changes?  
If the informant does not answer spontaneously, ask: 
If the changes have affected whether you can get things done 
How the changes have affected your relationship with your colleagues at work 
Family and friends 
Would you say that the changes have affected your relationship with your family and 
friends?
If yes: 
Can you describe these changes? 
If the informant does not answer spontaneously, ask: 
How the changes have affected your relationship with children 
How the changes have affected your relationship with your partner/spouse – 
your closeness and sexual relations 
How the changes have affected your relationship with friends 
100
Leisure activities 
Would you say that the changes have affected how you feel about leisure activities?
If yes: 
Can you describe these changes? 
If the informant does not answer spontaneously, ask: 
How the changes have affected your feeling about doing routine housework 
About participating in leisure activities 
About physical exercise 
Emotions
Health complaints will often affect us emotionally. Have you experienced that the 
changes have also affected how you feel on a normal day?  
If yes:
Can you tell me about these changes? 
If the informant does not answer spontaneously, ask about: 
Frustration
Being able to speak your mind 
Shame and/or guilt 
Sadness
Anxiety/feeling of security 
Happiness
Curiosity and exploratory inquisitiveness 
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Have the changes affected how you think about yourself?  
If yes:
Can you tell me about these changes? 
If the informant does not answer spontaneously, ask about: 
Your belief in being able to accomplish things 
Your feeling of self-esteem 
Your thoughts about your future 
Reflections
What was your reaction when you found out that your complaints might be associated 
with amalgam? 
What were your experiences when your amalgam fillings were replaced? 
What has been useful and positive in your experience of the amalgam replacement?  
  In relation to the replacement itself? 
In relation to the contact with the Adverse Reaction Unit? 
How is it/has it been to live with health complaints that people have so many strong 
opinions about?  
 In the media, in the health services and among family members and friends? 
Concluding question: 
”We are getting close to the end of the interview. We have touched on many different 
subjects, but there may well be things that you wonder about or thoughts you may have 
that I should have asked you about?”
102
Erratum
Paper I: page 838, in the last sentence in the caption to Table 1: “September 2000” is 
corrected to “September 2002”. 
